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Executive Summary 
Introduction 
The emergence of new kinds of interventions to improve health care quality and safety has led to 
a rethinking of traditional health services and clinical research. Interventions intended to improve 
quality and safety are often complex sociotechnical interventions whose targets may be entire 
health care organizations or groups of providers, and they may be targeted at extremely rare 
events. As such, evaluation of patient safety practices (PSPs) must be evaluated along two 
dimensions: the evidence regarding the outcomes of the safe practices and the contextual factors 
influencing the practices' use and effectiveness.  
 
The methodological criteria for assessing the quality of clinical intervention research and 
evaluation studies may be insufficient for studies of the effectiveness of organizational and 
behavioral change required to implement a safety practice. Indeed, researchers of PSPs often 
have to assess, as clinical researchers do, whether an intervention works. They also, as 
organizational and behavioral researchers do, need to determine whether such practices will 
work in their own settings, (i.e., will they benefit patients in their own organization with its 
unique attributes). In addition to questions of effectiveness (whether, how, and why interventions 
work), it is also important to consider unintended adverse consequences of implementing the 
safety practice. In other words, like medications, quality improvement (QI) and safety 
interventions can have side effects, which must be anticipated and measured. 
 
Origin of this Report 
Over the past decade, major concerns about the quality and safety of medical care have surfaced. 
Influential factors in our health care system such as government payers, accreditors, and 
employers have responded by creating a variety of incentives to promote quality and safety. The 
lack of consensus about the standards creates a risk that the substantial investment in new 
knowledge will be undermined by poor study design, flawed execution, or inappropriate 
interpretation of study results. In addition, policymakers are encouraging or requiring provider 
organizations to implement safe practices in the absence of explicit criteria for evaluating the 
strength of the evidence supporting the practice under consideration or evidence about the 
likelihood that patients will benefit.  
 
Recognizing this major gap in knowledge and understanding, AHRQ supported the development 
of a report to identify criteria for assessing the context-sensitive effectiveness and safety of PSPs. 
Context is a particularly crucial issue because it is believed to be a key factor differentiating the 
interpretation of PSPs from clinical interventions. Researchers, policymakers, and providers 
evaluating PSPs care not only whether robust evidence supports the PSP, but also whether and 
how they can implement the PSP in their organizations to improve patient outcomes. 
 
To address these gaps, the Agency for Healthcare Research and Quality issued a Request for 
Proposals (RFP) focused on developing criteria to assess the effectiveness and safety of PSPs. In 
the RFP guiding this project, PSPs are described as "interventions; systems, organizational, and 
behavioral interventions; and various combinations of these." To provide a real-world basis for 
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committee deliberations regarding the research questions, the study investigators, working with a 
panel of experts, chose to focus on five PSPs representing various aspects of the patient safety 
research field: 
 
1. Checklists for catheter-related bloodstream infection prevention. 
2. The Universal Protocol for preventing wrong procedure, wrong site, wrong person surgery. 
3. Computerized order entry/decision support systems. 
4. Medication reconciliation. 
5. Interventions to prevent in-facility falls. 
 
 
Methods 
In this 1-year project, we assembled a 22-member Technical Expert Panel (TEP) comprising 
international patient safety leaders, clinicians, policymakers, social scientists, and 
methodologists. We met with the TEP three times, performed many literature reviews, conducted 
five Internet surveys, and achieved consensus on the points below. 
 
 
Key Findings 
1. Important evaluation questions for these PSPs are: 
 
a. What is the effectiveness of the PSP? 
b. What is the implementation experience of the PSP at individual institutions? 
c. What is the success of widespread adoption, spread, and sustainability of the PSP? 
 
Interpretation and significance: Evaluations of PSPs should explicitly consider these three 
questions. Journals should consider asking researchers to report on them separately. Also, 
implementers will want to assess their experience across all three questions. 
 
2. High-priority contexts for assessing context-sensitive effectiveness at individual institutions 
are: 
 
a. Structural organizational characteristics (such as size, location, financial status, existing 
quality and safety infrastructure). 
b. External factors (such as regulatory requirements, the presence in the external 
environment of payments or penalties such as pay-for-performance or public reporting, 
national patient safety campaigns or collaboratives, or local sentinel patient safety 
events). 
c. Patient safety culture (not to be confused with the larger organizational culture), 
teamwork, and leadership at the level of the unit. 
d. Availability of implementation and management tools (such as staff education and 
training, presence of dedicated time for training, use of internal audit-and-feedback, 
presence of internal or external individuals responsible for the implementation, or degree 
of local tailoring of any intervention). 
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Interpretation and significance: Context is considered important in determining the outcomes of 
PSPs. The study investigators and the TEP judged these four domains as the most salient areas of 
context. This recommendation has broad implications for a variety of audiences. Researchers 
should be encouraged to measure and report on these contexts when describing a study of a PSP. 
Consumers of research will want to look for such reports, which will influence their 
interpretation of the study results and affect the applicability of the PSP to their setting. 
Accreditors and regulators should be reluctant to mandate adoption of a given PSP if it appears 
to be very dependent on context. In that case, they should also provide guidance on how that PSP 
might need to be modified depending on local contexts. 
 
3. There is insufficient evidence and expert opinion to recommend particular measures for 
patient safety culture, teamwork, or leadership. Given the plethora of existing measurement 
tools we identified and reviewed, our recommendation is to use whichever method seems 
most appropriate for the particular PSP being evaluated.  
 
a. For patient safety culture, the measurements methods with the most support were the 
AHRQ Patient Safety Culture Surveys, the Safety Climate Scale, and the related Safety 
Climate Survey. 
b. For teamwork, the most support was given to the ICU [Intensive Care Unit] Nurse-
Physician Questionnaire; no other measure received more than half the votes of 
respondents. 
c. For leadership, the measures receiving the most support were the ICU Nurse-Physician 
Questionnaire, the Leadership Practice Inventory, and the Practice Environment Scale. 
 
Interpretation and significance: Because the four areas of context described in Point 2, above, are 
judged highest priority, it will be crucial to develop and use valid measures of them in PSP 
studies. Researchers' use of common validated instruments would better enable readers to 
evaluate whether published results are applicable to their own settings. The state of the science 
here is immature, and funders and researchers are encouraged to continue to develop standard 
measures of the key domains of context. 
 
4. The PSP field would advance by moving past considering studies of effectiveness as being 
“controlled trials” versus “observational studies.” Although controlled trials offer greater 
control of sources of systematic error, they often are not feasible, either in terms of time or 
resources. Also, controlled trials often are not possible for PSPs requiring large-scale 
organizational change or PSPs targeted at very rare events.  Hence, strong evidence about the 
effectiveness and comparative effectiveness of PSPs can be developed using designs other 
than randomized controlled trials. However, PSP evaluators are to be discouraged from 
drawing cause-and-effect conclusions from studies with a single pre- and post-intervention 
measure of outcome. More sophisticated designs (such as a time series or stepped wedge 
design), are available and should be used when possible. 
 
Interpretation and significance: Given the major push to improve patient safety and the focus on 
evidence-based practices (which are rapidly embedded in national standards such as those issued 
by the National Quality Forum, the Joint Commission, the Institute for Healthcare Improvement, 
and others), it will be crucial to develop standards for appropriate evaluations to answer key 
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safety-oriented questions. The results above will help journal editors, funders, researchers, and 
implementers adopt robust study methods for PSPs, methods that most efficiently answer the key 
questions without undue bias. 
 
5. Regardless of the study design chosen, criteria for reporting on the following items in a PSP 
evaluation are necessary, both for an understanding of how the PSP worked in the study site, 
and whether it might work in other sites: 
 
a. An explicit description of the theory for the chosen intervention components, and/or an 
explicit logic model for “why this PSP should work.” 
b. A description of the PSP in sufficient detail that it can be replicated, including the 
expected change in staff roles. 
c. Measurement of contexts in the four domains described in Point 2, above. 
d. Details of the implementation process, what the actual effects were on staff roles, and 
how the implementation or the intervention changed over time. 
e. Assessment of the impact of the PSP on outcomes and possible unexpected effects. 
Including data on costs, when available, is desirable. 
f. For studies with multiple intervention sites, an assessment of the influence of context on 
intervention and implementation effectiveness (processes and clinical outcomes). 
 
Interpretation and significance: These criteria (items a-f) are deemed necessary for an 
understanding of PSP implementation and effectiveness and the degree to which these elements 
are sensitive to context. Future AHRQ-supported evaluations of PSP implementation should 
adhere to the criteria developed by this project. Only through repeated assessments and 
measurements will it be possible to determine the context-sensitivity of PSPs, build the evidence 
base for which contexts are most important, and determine how they should be measured and 
reported. 
 
 
Recommendations for Future Research 
Based on the group discussions and a formal vote by the TEP, the most important needs for 
future research are: 
 
1.  Developing and validating measures of patient safety culture. Discussion at the panel 
meetings indicated that several technical experts considered patient safety culture to be the 
overarching important construct. This view may explain why patient safety culture received 
majority support as a high priority for future research, whereas research on leadership and 
teamwork measures did not. Specific suggestions for future research included: 
 
a. Developing validated measures of cultural adaptability to change. 
b. Assessing the potential distinction between a culture of safety, a culture of excellence, 
and organizational culture. 
c. Establishing connections between aspects of patient safety culture and patient outcomes 
or processes of care. 
d. Assessing correlations between measures. 
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Additional comments that we received can be summarized as “we think teamwork and 
leadership are important," "several measures are currently available," and "the most 
important thing at this point is for people to use them so we can start building some evidence 
about this construct.” 
 
2.  Developing criteria and recommendations, for what constitutes "reporting the 
intervention in sufficient detail that it can be replicated.” More precise criteria for how 
PSP interventions should be described warrant additional research. In particular, the guidance 
described here, along with that provided by Standards for Quality Improvement Reporting 
Excellence (SQUIRE) and the National Quality Forum (NQF), need to be evaluated. Doing 
so will help determine which PSP elements need to be described in order to evaluate whether 
the PSP is truly effective. This also will help maximize the possibility of successful PSP 
replication with similar outcomes. Further research could also evaluate the effect of applying 
these draft criteria regarding PSP descriptions on the quality of PSP projects and published 
articles. Clearly, thoroughly describing PSPs also can help readers determine the relevance of 
an evaluation study to other PSPs or other contexts. For example, if a PSP requires an 
individual behavior change such as hand-washing, then knowing intervention details may 
help readers of the study assess whether the given results are relevant only to hand-washing 
interventions or if they could be applied to other types of PSPs requiring individual behavior 
change. Knowing the details of the intervention also could help readers of the study 
determine how much the success of the PSP implementation depended on contextual issues 
(e.g., organization or teamwork).  
 
3. Understanding the important items to measure and report on for implementation. 
Experts consider having comprehensive information about implementation key to being able 
to replicate a PSP. However, little empirical evidence exists about what makes a description 
of the PSP adequate for reporting. Assessing what implementers need to know, if they are to 
be able to implement or adapt an intervention in their own settings, is critical. Most experts 
considered "understanding the important items to measure and report on for implementation" 
to be related to or even the same as "reporting the intervention in sufficient detail that it can 
be replicated."  This view suggests that the distinction between “the intervention” and “the 
implementation” may be an arbitrary line, and that ideal evaluations of PSP interventions 
need to consider the implementation as part of the intervention. 
 
4.  Developing a theory-based taxonomy or framework with which to describe and 
evaluate key elements of interventions, contexts, and targeted behaviors. Although the 
current project made a promising start on meeting this need, progress in this area will require 
additional development to produce a taxonomy that would be both sufficiently broad based 
and flexible enough to be widely useful. Issues to be considered include whether a taxonomy 
is the preferable way to proceed, or whether a more useful strategy might be to create an 
explicit methodology that researchers could apply to specific problems and contexts. Yet 
another approach might be to devise an “assessment framework.”  Some experts sounded 
cautionary notes on this topic. They reported that outpatient PSP research may be too new to 
apply a taxonomy at this stage. They also reported that a single “unified” taxonomy may not 
be sufficiently flexible for diverse PSPs, and multiple taxonomies may be needed in any case. 
The countervailing view to these cautionary notes was that the field would not be well-served 
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by having a proliferation of taxonomies.  Instead, they reported, what is needed is a coherent, 
sufficiently comprehensive taxonomy that can accommodate the challenges of the subject. 
 
5. Refining a framework for assessing the strength of a body of evidence. We did 
developmental work on an adaptation of the GRADE and Evidence-based Practice Center 
(EPC) systems for assessing the strength of evidence across studies of a PSP. This work 
warrants further development. 
 
6. Generating empirical evidence that the contextual factors identified in this project 
influence the success of the PSP. We acknowledge that most of the recommendations in the 
report have a thin empirical evidence base, which simply reflects the relatively immature 
state of research in this still relatively young field. Building a stronger evidence base will 
help future efforts at refining the recommendations presented here.  
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Chapter 1. Introduction  
Patient safety research is a fairly young field that received substantial investment in the United 
States after the Institute of Medicine’s 1999 landmark report To Err is Human sounded the alarm 
and resonated with the public. They heard the salient sound bite that one “jumbo jet” of patients 
dies each day from a medical error. In rapid response, the lead Federal agency for health care 
quality research, the Agency for Healthcare Quality and Research (AHRQ), commissioned an 
evidence-based practice center (EPC) team of researchers to develop an evidence report of 
“patient safety practices” (PSP). The resulting report, Making Health Care Safer: A Critical 
Analysis of Patient Safety Practices, identified 79 practices, ranging from targeted clinical 
interventions (e.g., the use of antibiotic-impregnated catheters to prevent urinary tract 
infections), to clinical procedural enhancements (e.g., visualizing central line placement to avoid 
inadvertent lung puncture), to broad system changes (e.g., promotion of a culture of safety and 
teamwork to reduce a range of possible failures in patient safety).1  Because the evidence for the 
effectiveness of these PSPs was scant, according to the established evidentiary review lens 
available to the EPC at that time (which was in use by the global consortium of systematic 
review experts, the Cochrane Collaboration and their Effectiveness of Practice and Organization 
of Care (EPOC) group),2 the complex, systems-oriented PSPs did not rise to the top of the list of 
PSPs recommended for further implementation.  
 
These EPC recommendations, while explicitly based on only one potential approach to distill the 
evidence on practices, stimulated an important debate about whether the evidentiary lens needed 
adjustment for application to patient safety practices. The issues on either side of the debate are 
well presented in two “Controversies” articles published in JAMA in 2002,3, 4 and taken up again 
more recently in other publications.5-10 The interest in determining the approach to evidence 
evaluation for patient safety was also highlighted at the Second National Summit on Patient 
Safety Research sponsored by the Quality Inter-Agency Coordination Task Force (QuIC) in 
November 2003.11 The panel reinforced that often it is not possible or practical to evaluate 
implementation performance using randomized controlled trials (RCTs), and as a result, 
concluded that other types of research designs should be considered. In addition, the panel 
recommended that AHRQ develop standards for patient safety research, as well as for synthesis 
of a body of evidence on a given PSP, based on a range of suitable research designs and analytic 
methods. Over the ensuing years, further efforts by national and international organizations (e.g., 
the National Quality Forum (NQF), the Joint Commission’s International Center for Patient 
Safety) have focused on approaches to identifying, prioritizing, and recommending further 
development and dissemination of PSPs or “Patient Safety Solutions.”12 
 
AHRQ initiated the current project to respond to the debate on what constitutes evidence in 
patient safety by engaging in a structured process with experts from a broad range of pertinent 
fields, including human factors, organizational behavior, management sciences, public health, 
evaluation sciences, implementation sciences, biostatistics, clinical medicine, evidence-based 
medicine, and patient safety. The overarching charge to the research team and expert panel was 
to assist AHRQ in developing “criteria for assessing the evidence base for the context-sensitive 
effectiveness and safety of patient safety practices," or how the contexts (within which a patient 
safety practice is implemented) can affect the effectiveness of that implementation. This charge 
emanates from a well-articulated rationale described by AHRQ per the Request for Proposal 
(RFP) that guides this project, and it is summarized by the project team in Figure 1.  
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The diagram’s upper part displays a PSP, its context, and potential results from localized testing 
or full-scale roll out. The lower half of the diagram stylizes the key components of evaluation 
and how they need to be fit together in evidence synthesis. The middle line represents the needs 
of patient safety stakeholders for criteria to assess which patient safety practices work and in 
what context. Essentially, this project aims to strengthen the line between the top and bottom half 
of this diagram. Each part of the diagram is described further in the following sections to provide 
a brief rationale for the project. 
 
Diagram Component: Patient Safety Practices 
In the RFP that led to this project, AHRQ defined patient safety practices as “interventions, 
strategies, or approaches intended to prevent or mitigate unintended consequences of the delivery 
of health care and to improve the safety of health care for patients. PSPs may include clinical 
interventions, systems’ organizational and behavioral interventions, and various combinations of 
these.”  
 
As implied by this definition, PSPs often include components that often are constructed 
differently at different points in time or in different settings. Figure 1 shows a generic PSP, with 
small empty boxes as placeholders to describe the PSP’s components. The definition also 
highlights the diversity of PSPs and the potential for combining them to develop new PSPs.  
 
.  
Figure 1. Rationale for examining patient safety practices to assess their effectiveness 
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Diagram Component: Context 
The oval around the PSP in Figure 1 represents the organizational, behavioral, and broader 
environmental context in which the PSP is embedded. Numerous leaders in patient safety 
research have articulated the importance of context. In a forthcoming review for the World 
Health Organization, John Øvretveit and colleagues state that an intervention’s effectiveness and 
safety may vary according to context because of implementation differences, the need for 
adaptation of implementation, and interactions between contextual factors and the intervention, 
which result in modification to the intervention over time (Personal communication). Some PSPs 
address specific evidence-based therapies, while other PSPs are more abstract or diffuse, such as 
"training clinicians in teamwork." Local factors (such as staffing considerations) may require 
changes in order to make the PSP implementable given the local or wider context. Thus, 
interventions that appear to be the same or carry the same label may in fact be quite different 
when implemented in various places and timeframes; and such differences may account for 
different outcomes. These considerations support a requirement that studies provide precise 
descriptions of the evaluated intervention, along with relevant features of the intervention 
context, including implementation processes.  
 
For many complex interventions, there is a paucity of information about context and its interplay 
with the PSP. For example, the 2006 AHRQ EPC report on Health Information Technologies 
(health IT) by Shekelle and colleagues found that the interventions studied included not just the 
technical aspects of the computer and software, but also the human factors, the project 
management, and the organizational process change; and that these contextual factors were not 
adequately described, making it is difficult for others to apply the study results to actual health 
care settings.14 In another AHRQ EPC project on care coordination interventions to improve 
health care quality and patient safety, McDonald and colleagues noted the need for context-
flexible evaluations tied to theory, as well as actual needs of quality improvement 
implementers.15 The authors called for more detailed descriptions of both the interventions and 
the contexts in which they were tested to make any conclusions about outcomes more readily 
interpretable to those choosing potential intervention strategies for their particular circumstances. 
Thus, EPC investigators have also recognized the importance of context. 
 
There is no standard definition of "context." It may include detailed information about processes 
of implementation, as well as barriers and facilitators related to the organizational and policy 
environment in which a PSP is implemented. These factors have been shown to be critically 
important to understanding the success or failure of a PSP. For example, Pronovost and 
colleagues discussed the importance of considering local context while maintaining standardized 
measures and evidence in their effort to reduce blood stream infections in Michigan.16 They 
found that it was both efficient and effective to standardize the technical aspects of quality 
improvement programs while encouraging local modification of how the evidence is put into 
practice. Similarly, a recent evaluation of the World Health Organization (WHO) surgical 
checklist found an overall reduction in adverse events; yet this was not consistent at all sites (see 
http://www.who.int/patientsafety/safesurgery/ss_checklist/en/index.html). Evaluation of the 
implementation effectiveness or barriers and facilitators will be important in attempts to 
disseminate the WHO surgical checklist across the world.17  
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Diagram Component: Results 
Use of a PSP in a particular context may result in positive and negative outcomes (including 
unintended harms), shown as effectiveness and harms respectively in the box on the right hand 
side of Figure 1. In addition to these critical outcomes, other potentially important effects include 
those related either to implementation (e.g., uptake, cost, and ease of implementation initially) or 
widespread adoption and spread of a PSP. Figure 1 is a simplification, but nevertheless, it posits 
that the effectiveness, safety, and other outcomes of a PSP may be affected by its specific 
components; where, when, and how the PSP is implemented; and with whom and for what 
purposes the PSP is used; as well as by features of the external environment or larger context. 
 
Diagram Component: Criteria and Knowing What Works  
The middle dotted line in Figure 1 sets up the overarching objective of the current project. To 
inform stakeholders interested in improving patient safety about what works in which contexts, 
AHRQ has called for context-sensitive criteria to assess PSPs. Therefore, the goal of developing 
criteria and guidance on evaluations of PSPs is to understand the relationships between PSPs and 
their intended and unintended results in particular contexts and configurations. Specifically, the 
agency suggests that:  
 
Establishing more appropriate criteria for evidence reviews of patient safety practices can be 
expected to have three closely related effects. First, the criteria should broaden the scope of 
patient safety practices that can be assessed for effectiveness and safety based on scientific 
evidence. Second, the availability of the criteria will strengthen research studies that are 
assessing those practices. Third, if developed in a way that is usable to implementers of 
patient safety practices beyond researchers (e.g., individual clinicians, health policymakers, 
and patient advocates), criteria can be applied in situations where PSPs should be evaluated 
for individual and institutional learning without regard to publication in peer-reviewed 
journals (per the RFP for this project; see  www.ahrq.gov/fund/contarchive/rfp0910001.htm). 
 
Diagram Component: Evaluation and Synthesis 
For context-sensitive evaluation of PSPs, evidence synthesis promises to assemble information 
from individual studies, ultimately determining how to draw together information for each of the 
four puzzle pieces (Figure 1):  
Constructs about the PSP, its components, context factors, outcomes, and ways to measure 
accurately these constructs.  
Logic model or conceptual framework about the expected relationships among these constructs.  
Internal validity to assess the PSP results in a particular setting.  
External validity to assess the likelihood of being able to garner the same results in another 
setting.  
 
A number of individual studies, with a broad range of research and evaluation designs, may be 
needed to answer satisfactorily the many questions of interest to the patient safety field for a 
given PSP. Initial key questions for evaluation and synthesis put forth by AHRQ include those 
focused on effectiveness, implementation, and adoption or spread. 
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In summary, this project aims to advance the patient safety field by using targeted literature 
reviews and structured expert panel consultation to present a conceptual framework and a set of 
rigorous evaluation criteria for assessing and guiding studies on PSPs and their contexts. The 
report presents an initial conceptual framework, initial criteria, and a path toward developing a 
comprehensive set of rigorous evaluation criteria for assessing and guiding studies on PSPs and 
their contexts. Based on the framework and criteria, we identify the types of research and 
evaluation models and methods that experts judge to be most useful for advancing the field of 
patient safety. We develop specific criteria for assessing the rigor of individual studies; we also 
lay out methods and criteria for synthesizing sets of studies to assess the overall body of 
evidence related to specific PSPs and their contexts. Finally, we identify issues and questions for 
future analysis of and research on PSP methodology.  
 
The litmus test for the project will ultimately come from those on the frontlines of patient safety 
improvement efforts. What information will help those who are accountable for their health 
system or the Nation’s performance in terms of health care quality and patient safety? What 
methodology guidance will enable those who are conducting systematic evidence reviews to 
address key questions about PSPs? What material in the report will ease the process of primary 
knowledge generation for researchers and evaluators of PSP interventions? What take-home 
messages will support research funders’ ability to continue to move the field forward to its 
ultimate goal of making health care substantially safer for the public? These questions shape the 
reporting of our approach and recommendations in the subsequent chapters. 
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Chapter 2. Methods  
 
This project represents a collaboration between the project team and an interdisciplinary group of 
patient safety and methods experts, called the Technical Expert Panel, or TEP. Each key step of 
the project required both preparatory work on the part of the project team and then consideration 
and discussion by the TEP, with synthesis of the TEP discussion and decisions then made by the 
project team. The figures on the following pages give an overview of the methods, which are 
more fully described in Appendix A, Part 1. 
 
The five goals of the project were to: 
1. Form an interdisciplinary panel of experts to assist with all phases of the project.  
2. Identify a diverse and representative set of patient safety practices to be used as initial 
subjects. As noted in the RFP, "to help iteratively develop criteria for rigorous and systematic 
assessment of the context-sensitive effectiveness and safety of PSPs. They should be in 
actual use, promising in terms of underlying logic models for achieving effectiveness, safety, 
and generalizability, …address high impact and diverse patient safety problems, and 
represent the contexts in which patient safety is an important concern…" 
3. Identify research and evaluation models, methods and designs to rigorously evaluate the 
patient safety practices identified and, "in considering research designs and methods,” 
identify or develop approaches that measure contexts and implementation processes in PSP 
interventions and suggest how collection of contextual and process data needed for assessing 
the generalizability of the PSP can be combined with designs that are strong on internal and 
construct validity. Pay close attention to assessing both the positive and negative impacts of 
PSPs. Pay close attention to identifying appropriated measures of aspects of the PSP." 
4. Develop a set of criteria, including criteria for strength of evidence, to be used for assessing 
future studies and reports. Criteria are necessary to guide both (a) future assessments of 
evidence and safety relative to the effectiveness, implementation, and adoption of the 
identified types of PSPs; and (b) systematic reviews of patient safety evidence. 
5. Identify specific needs for future development of theories, constructs, and 
research/evaluation designs and methods to further strengthen evaluations of PSPs and 
criteria for systematic review. 
 
In Figure 2, the selection of the “diverse and representative patient safety practices” (goal 2 
above), the project team used the literature, expert input, and information from other sources 
(such as the project officer, the RFP, etc.) to develop a list of candidate PSPs. This list was then 
voted on by the TEP, and the results of the vote were used by the project team to select four 
PSPs, based on a number of criteria such as setting, regulated use, etc., presented in more detail 
later. There were remaining questions about the need for a possible fifth PSP, and this too was 
put to the TEP in an e-mail vote. The results of this process led to the final set of five diverse and 
representative PSPs, which was affirmed by the TEP.   
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Figure 2. Selection of the diverse and representative patient safety practices (PSPs) 
 
 
In Figure 3, regarding evaluation questions, the project team (again using the literature, input 
from experts, and their own experiences in quality improvement and patient safety research) 
developed a draft monograph proposing three basic types of evaluation questions. This 
monograph was reviewed by the TEP and then discussed at the July 17, 2009 TEP 
teleconference. A revised set of evaluation questions was then prepared reflecting the TEP’s 
input. 
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Figure 3. Evaluation questions  
 
 
In Figure 4, regarding study designs, the project team used existing literature plus input from 
experts, including key methods experts on the TEP, to come up with a framework of study 
designs linked to evaluation questions and contexts. The issue about study design continued to be 
a topic of discussion at the July 17, 2009 TEP teleconference, as well as the November 4-5, 2009 
face-to-face TEP meeting. The results informed the report chapter on study design, presented in 
Appendix I, as well as the criteria for evaluating the body of evidence. An important result of 
this process was the TEP's recognition that prior arguments conceptualizing the issue as 
“randomized controlled trials” versus “observational study designs” obscured important elements 
of assessment that should be included in any well-done evaluation. Another important result of 
this process was the TEP's agreement on which of those assessment elements were most critical. 
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Figure 4.  Selecting Study Designs 
 
Figure 4.  Selecting study designs 
 
 
 
In Figure 5, regarding the selection of contexts, the project team again used existing literature, 
theory, and expert input to come up with a candidate list of potential contexts important for 
assessment in this project. This list was shortened as a result of TEP input in an Internet survey 
plus discussion at the July 17, 2009 TEP teleconference. This shortened list was then the subject 
of a literature review by the project team, assessing the evidence for the influence of these 
contexts on implementation effectiveness or outcomes. This information helped guide a 
discussion by the TEP at the November 4-5, 2009 meeting. Subsequently, a revised Internet 
survey was completed by the TEP, resulting in the final list of contexts. 
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Figure 5. Selecting contexts 
 
 
In Figure 6, regarding selection of criteria for assessing context-sensitivity, the project team 
took the shortened list of contexts and reviewed available methods of measuring the key contexts 
that present measurement challenges (teamwork, leadership, patient safety culture, and 
organizational complexity). This literature review, in addition to the review of evidence 
developed in Figure 5, was then used by the TEP to select criteria for measuring these contexts. 
This was done during a discussion at the November 4-5, 2009 TEP meeting and in a subsequent 
Internet survey. 
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Figure 6. Selecting criteria  
 
 
Finally, to identify specific needs for future development and research, we first surveyed the 
project team. We then received feedback from the project officer as well as the project team 
before surveying the entire TEP after the November 4-5, 2009 meeting. 
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Chapter 3. Forming an Interdisciplinary Panel of 
Experts 
 
The technical expert panel (TEP) is a very important aspect of the project. Panel composition 
matters, both in terms of the panel output and the external credibility of the output. In short, one 
wants the most relevant disciplines to be represented by the experts with the greatest external 
credibility in their field, since others in their field will in part base their acceptance of the 
resulting criteria on their trust in the experts who contributed to the development.  
 
With these principles in mind, we formed an expert panel with broad representation in terms of 
both the methods of evaluation of effectiveness, implementation, and safety and in terms of 
diverse groups of patient safety literature stakeholders. We included recognized experts from 
different patient safety topic areas (such as health IT, hospital-acquired infections, etc.), plus 
front line health care delivery experts and a journal editor. The members of the TEP are listed in 
Table 1, and their bioparagraphs can be found in Appendix A, Part 2. 
 
Table 1. Expert panel members: Stakeholders and methodologists 
Name Qualifications 
Dr. Alyce Adams Brings expertise on the determinants of suboptimal use health care services 
among disparities populations, including racial differences in medication 
adherence and the impact of changes in health policy on access to high quality 
health services and health outcomes for vulnerable patients. 
Dr. Peter Angood Inaugural Senior Advisor for Patient Safety at the National Quality Forum 
(NQF), overseeing development and maintenance of the NQF Safe Practices 
program and the NQF Serious Reportable Events program and providing 
oversight for NQF-endorsement of Measures for Patient Safety. 
Dr. David Bates  
 
Brings an information technology and medication safety perspective and helps 
lead the Center of Information Technology Leadership at Partners HealthCare 
System, Inc; served as the Center Director on one of three national Centers of 
Excellence in Patient Safety and Research supported by AHRQ.  
Dr. Leonard 
Bickman 
Brings expertise in quantitative methods, health services research, and 
program evaluation; Betts Professor of Psychology and Director of the Center 
for Evaluation and Program Improvement, Peabody College, Vanderbilt 
University. 
Dr. Pascale 
Carayon 
Brings expertise in human factors engineering and is the Procter & Gamble 
Bascom Professor in Total Quality and the Director, Center for Quality and 
Productivity Improvement at the University of Wisconsin, Madison. 
Professor Sir Liam 
Donaldson  
Chief Medical Officer for England, United Kingdom; principal advisor to the 
United Kingdom Government on health matters and one of the most senior 
officials in the National Health Service (NHS). International leader in health 
care quality and safety and director of the WHO World Alliance for Patient 
Safety.  
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Name Qualifications 
Dr. Naihua Duan An accomplished practicing biostatistician with research interests in health 
services research, prevention research, and sample design and experimental 
design, a Professor of Biostatistics (in Psychiatry) at Columbia University, and 
the Director of the Division of Biostatistics and Data Coordination at New York 
State Psychiatric Institute. 
Dr. Donna Farley An expert at conducting rigorous program evaluations of quality improvement 
initiatives and patient safety interventions who led RAND’s Patient Safety 
Evaluation Center, funded by AHRQ, to evaluate the Federal Government’s 
national patient safety initiative. 
Dr. Trisha 
Greenhalgh 
A general practitioner with research expertise in complex innovation in health 
care, especially electronic health records and the use of narrative methods in 
health services research. 
Dr. John Haughom Senior Vice President of Clinical Quality and Patient Safety for PeaceHealth, a 
non-profit, integrated health care system in the Pacific Northwest; responsible 
for clinical improvement, patient safety initiatives, health services research, 
outcomes measurement, and all information systems initiatives. 
Dr. Eileen Lake Brings expertise on the contributions of the nurse's work environment and 
clinical nursing expertise to patient outcomes, as well as expertise on methods 
for outcomes research. 
Dr. Richard Lilford A physician with expertise in Bayesian analysis and interests in patient safety 
(particularly as applied to obstetrics/gynecology) who co-authored the recent 
four-part series on “An epistemology of patient safety research.” Dr. Lilford’s 
associate, Dr. Celia Brown, attended the first TEP meeting in his place. Dr. 
Brown brings expertise in the epistemology of patient safety research and in 
economics, public health, epidemiology, and biostatistics. 
Dr. Kathleen Lohr Brings over 35 years of experience in health services and policy research; was  
founding director of the RTI International–University of North Carolina 
Evidence-based Practice Center and the RTI DEcIDE Center; now serves as 
senior advisor to both. 
Dr. Gregg Meyer Expert in quality improvement; Senior Vice President for the Center for Quality 
and Safety at Massachusetts General Hospital; Co-chairman, NQF Executive 
Institute Task Force on Safe Practices; and previously, Director of AHRQ’s 
Center for Quality Improvement and Patient Safety.   
Dr. Marlene Miller Expert in pediatric quality and patient safety; Vice Chair for Quality and Safety, 
Johns Hopkins University Children’s Center; Vice President of Quality 
Transformation for the National Association of Children’s Hospitals and 
Related Institutions.   
Dr. Duncan 
Neuhauser 
A health services researcher, nationally recognized for research in hospital 
management, quality improvement, and clinical decision analysis. 
Dr. Gery Ryan An expert in a wide range of qualitative methodology and research and 
evaluation design. 
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Name Qualifications 
Dr. Sanjay Saint Director of the VA/University of Michigan Patient Safety Enhancement 
Program; his research focuses on hospital-acquired infections. 
Dr. Kaveh 
Shojania 
A leader in identifying evidence-based patient safety interventions and 
effective strategies for translating evidence into practice; co-authored EPC 
patient safety reports with Wachter. 
Dr. David Stevens Leader of the SQUIRE project, the editor of the journal Quality and Safety in 
Health Care, is with AHRQ’s Center for Quality Improvement and Patient 
Safety, and directs the Association of American Medical Colleges’ Institute for 
Improving Care. 
Dr. Steve Shortell Dean of the UC Berkeley School of Public Health and an expert in 
organizational management and behavior, quality improvement, and health 
services research. 
Dr. Kieran Walshe A health services researcher who is an expert in theory-driven evaluation and 
in clinical and organizational governance. 
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Chapter 4. Determining the Target Patient Safety 
Practices 
 
We selected five types of patient safety practices (PSPs) for the diverse and representative set 
of practices on which the rest of this project focused:  
1. Checklists for catheter-related bloodstream infection prevention. 
2. Universal Protocol for preventing wrong procedure, wrong site, wrong person surgery. 
3. Computerized physician order entry and decision support system. 
4. Medication reconciliation.  
5. Interventions to prevent in-facility falls. 
 
We selected these five PSPs after conducting a series of activities, one of which was a survey 
of the TEP. The full results of that survey are found in Appendix B. Our definitions for the 
PSPs follow. 
 
Universal Protocol 
The Universal Protocol for Preventing Wrong Site, Wrong Procedure, Wrong Person Surgery 
was created by the Joint Commission and became effective in 2004.1 The protocol consists of 
three components: conducting a pre-procedure verification process, marking the procedure 
site, and a ‘time out” session before starting the procedure. The protocol targets a very rare 
event but one that presumably is a preventable event.2  It was designed to address surgery 
errors with tragic consequences but has since been adopted in other fields or has been 
expanded to non-surgical fields.3 The Joint Commission recommends the use of a checklist 
but does not mandate it. Checklists seem to be a prominent way to implement the Universal 
Protocol and to ensure that its components actually take place. 
 
Medication Reconciliation 
Medication reconciliation is the practice of acquiring an accurate medication history at each 
transition in care.4 It aims to reduce adverse drug events that result because of medication 
information that is lost as patients transfer from one setting to another. Many different 
medication reconciliation interventions have been developed for use by health care providers, 
but most rely on two main components: 
1. Development of forms and procedures to capture information and compare for 
discrepancies from different sources (e.g., primary care, admission, discharge). 
2. Work flow and role assignment among providers (and sometimes patients). 
 
In addition, interventions often include education of providers (and sometimes patients) on 
the new processes and paperwork (or electronic tools) and audit and feedback regarding 
compliance with the process and the benefits of reconciliation. 
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Computerized Physician Order Entry (CPOE) and Decision Support 
Systems (DSS) 
CPOE can be thought of as direct entry of medical orders into the computer. DSS has been 
described as "a wide range of computerized tools directed at improving patient care, 
including computerized reminders and advice regarding drug selection, dosage, interactions, 
allergies, and the need for subsequent orders."5 However, DSS vary substantially in their 
features and capabilities.6 In this context, DSS refers to decision support regarding 
prescribing to help reduce adverse drug events (check for dosing errors, drug-drug 
interactions, etc.). 
 
Fall Prevention Programs 
Many different interventions have been developed to prevent falls, including multifactorial 
falls risk assessment and management, exercise, environmental modifications, education, and 
review of drugs, and programs that target risk factor reduction (identifying and reducing fall 
risk factors that can be removed or reduced). Risk factor reduction is one component in most 
programs (e.g. a clinical medication review by a pharmacist and treatment of care home 
residents). Most falls prevention interventions in institutions are a combination of 
components (multi-factorial) that may be prescribed for the implementers by label in a 
“bundle” (e.g., “implement an education program for staff and residents, risk assessment, 
non-slip mats, and medications review – how you do this is up to you”) or not prescribed for 
the implementers, instead it is a “menu” of labels and examples from which implementers 
choose. 
 
Blood Stream Infection Prevention Efforts 
A large variety of patient safety interventions have been evaluated for reducing central line-
associated bloodstream infections (CLABSI).7 Most are technical, such as avoiding the 
femoral insertion site and use of specific skin disinfection solutions. However, more recently, 
a few studies have been oriented towards quality improvement and human factors issues, 
including elements such as staff education, infection control programs, and feedback. We 
defined the patient safety practice for catheter-related infection or CLABSI prevention as 
practices, policies, or checklists to reduce the rate of infections acquired as a result of 
placement and maintenance of intravascular catheters in hospitalized patients. 
 
 
References for Chapter 4 
1. The Universal Protocol for Preventing Wrong Site, Wrong Procedure, and Wrong Person 
Surgery. Washington, DC: The Joint Commission; 2009. Available at  
http://www.jointcommission.org/PatientSafety/UniversalProtocol/. Accessed March 
2010. 
2. Kwaan MR, Studdert DM, Zinner MJ, Gawande AA. Incidence, patterns, and prevention 
of wrong-site surgery. Arch Surg. 2006; 141:353–7. 
3. Angle JF, Nemcek AA, Cohen AM, et al. Quality improvement guidelines for preventing 
wrong site, wrong procedure, and wrong person errors: Application of The Joint 
Commission "Universal Protocol for Preventing Wrong Site, Wrong Procedure, Wrong 
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Chapter 5. Key Evaluation Questions 
 
Our framework is based on three key types of questions that describe three different aspects 
of patient safety practice (PSP) evaluation (Figure 7).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Three Types of Evaluations Assessing the Results of Implementing PSPs  
 
 
Figure 7. Three types of evaluations assessing the results of implementing PSPs 
 
 
We hypothesized that fully addressing context-sensitive effectiveness and safety would 
require studies addressing all three types of PSP evaluation questions, and that each 
evaluation question type would imply different methodological approaches. While an 
important result of this project is a more expansive view of the characteristics of ideal studies 
of PSP implementations, effectiveness questions are often assessed using experimental or 
quasi-experimental designs; implementation experience questions frequently use a pre-post 
design; and adoption, spread, or sustainability questions would require, at a minimum, 
observational or descriptive designs. Questions on context sensitivity could be framed in 
terms of each type of evaluation. The information on effectiveness; implementation 
experience; and adoption, spread or sustainability in relationship to context would be part of 
the full picture of final judgments on context-sensitive effectiveness and safety.  
 
The conceptual framework we defined is in line with the multi-modal approaches often used 
in the PSP field. Saying that an effectiveness study should have information on the process or 
completion of implementation relative to context, for example, will be meaningless if 
recognition is not also given to the multiple designs indicated by the different types of 
questions. In other words, we are not interested in someone’s opinion of the implementation 
process or of how context affected it; we are interested in data. The randomized trial that 
reports an overall PSP effectiveness result without data on context often cannot be effectively 
applied. Similarly, knowing that small size practices did worse on PSP outcomes than larger 
ones (context) may be somewhat useful, but it is not likely to be as useful if data have not 
been collected to understand what went wrong in the smaller practices. For example, was the 
1.  Effectiveness Questions  
- Is the study PSP more effective than usual care? 
- Is the study PSP more effective in reducing  patient harm than an alternate approach? 
     
2.  Implementation Experience Questions  
- What changes occur in the clinical or economic performance of the study organization/organizational unit 
during/after implementation of the study PSP?   
- What changes occur in staff/clinician culture/attitudes during/after implementation? 
     
3.  Adoption or Spread Questions  
- How easily did the study PSP spread (economy/costs, speed/timeline for implementation, #/proportion of 
organizations/units adopting)? 
- How well/easily was the study PSP maintained (maintenance costs/resources, duration of implementation)?  
- Were there any unintended changes or incidents during or after implementation? 
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PSP fully implemented in these practices? Did small size practices that succeeded better in 
implementing the PSP show greater impact on expected outcomes? Thus, combined 
approaches are favored that simultaneously seek rigor in precision regarding effectiveness 
while also reporting key contextual features and, if possible, assessing contextual inferences 
on the outcomes of effectiveness, implementation experience, and adoption or spread.  
 
Within the timeline for this project, we focused most of our efforts on the first evaluation 
question – effectiveness and how it is influenced by context – and did not at all address the 
evaluation questions about adoption and spread.  
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Chapter 6. Description of Ideal Evaluation Methods: 
Overview  
 
The overriding finding of our project is that in order to better understand the context-
sensitivity of the effectiveness and safety of patient safety practices (PSPs) we need to move 
past the discussion of the merits of the traditional study designs aimed at assessing causality 
(e.g., “randomized trials” versus “observational studies”). We also need to pay far more 
attention to other important features currently missing from most published reports of PSP 
implementations. These features include: 
 
• A presentation of why or how the PSP should work. What is the theory supporting why 
this particular intervention should influence the target patient safety outcome? What is the 
logic model for how the PSP should work? 
• A description of the PSP in sufficient detail that readers could replicate it. PSPs are often 
complex interventions and cannot be described in only a few sentences. 
• A description of key contextual domains.  
• A description of the implementation process. For many PSPs, the line between the 
intervention and the implementation is not sharp, and the intervention and 
implementation may be considered to be a single construct. 
• An assessment of what actually happened during implementation of the PSP. What went 
as planned, and what happened that was unexpected? 
• An assessment of the results achieved, including benefits and harms. 
• An analysis of how the effectiveness and safety of the PSP varied as a function of the key 
contextual domains. 
 
The remaining seven chapters of the report address these features in more detail. 
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Chapter 7. The Importance of Theory 
“There is nothing so practical as a good theory” 
Kurt Lewin (1952) 
 
Hand-washing by hospital staff is a patient safety practice widely advocated to reduce hospital 
infections. But how does hand-washing work to reduce infections? On one level, it is because 
bacteria cause disease, and hand-washing kills bacteria. On another level, a handwashing policy 
works because—and only to the extent that—staff regularly wash their hands between patients. 
Those in charge of implementing handwashing policies might come up with a range of ideas for 
achieving regular handwashing, such as installing motion-activated alcohol-based antibacterial 
dispensers at every room entrance in the hospital or instituting an educational campaign that 
emphasizes doorways as the reminder to wash your hands (e.g. “every time you pass through a 
door, wash your hands”).  
 
The above paragraph contains two types of "theories" regarding the effectiveness of 
handwashing. The first is a theory of how handwashing reduces hospital acquired infections. The 
second is a theory of how to establish handwashing as business-as-usual in a particular 
organization. More generally, theories about patient safety practices (PSPs) may fall into two 
types: theories about how a given PSP results in better patient outcomes (sometimes called the 
"PSP action theory") and theories about how to establish and implement PSPs (so-called "PSP 
implementation theory"). Both types of theory are important. It would be difficult to promote a 
particular PSP without a rationale for why it might reduce harm, and knowing the PSP 
implementation theory enables decisionmakers and those responsible for implementation to 
understand the mechanisms of action at the study site and thus to devise ways to carry out similar 
actions and changes in their situation. In practice, it may be difficult to reliably distinguish 
between the two types of theory (how a given PSP works and how to implement it), as PSPs are 
often multifaceted or embedded within more complex programs.  
 
Changing provider and organizational behavior to apply effective PSPs in routine clinical 
practice is challenging. The implementation of PSPs has only recently become the subject of 
research. Implementation success is known to vary. This variation may be due to differences in 
implementation methods, in implementation fidelity, and also in differences in the context in 
which implementation is performed. However, such studies of change rarely describe the 
implementation or the context and do not allow “generalization through theory,” often a more 
efficient and appropriate method of generalization than study replication in many possible 
settings. Neither do they provide theories that might explain variations in outcomes. Without 
these descriptions or explanations, decisionmakers lack information to make choices about what 
is required for successful implementation of PSPs in their service and how to implement them 
effectively.  
 
One way forward is to carry out multiple studies of PSP implementation in many settings so that 
decisionmakers can learn from studies in settings similar to theirs. For example, audit and 
feedback are variably effective in changing provider behavior and clinical outcomes.1 The effects 
of this intervention may vary according to elements such as content of feedback (e.g. 
comparative or not, anonymous or not), intensity (e.g. monthly, annually), method of delivery 
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(by peer, or non-peer), duration (6, 12 or 24 months), and context (intensive care or nursing 
home). Varying only five elements produces 288 combinations, without accounting for the need 
for replication or addition of co-interventions.2 An alternative and more realistic and efficient 
approach is to use theories relevant to PSP implementation within evaluations and provide 
information that allows decisionmakers to better assess implementation feasibility or how best to 
implement the PSP. For example, an evaluation of implementation of an electronic medical 
record at a hospital in Sweden was based on theories of implementation. The authors' finding 
that implementation success was associated with factors in Rogers' Theory of the Diffusion of 
Innovation (plus additional factors postulated by previous research) strengthens our confidence 
in the usefulness of that theory and those factors to predict successful implementation in other 
settings.3  
 
What is “the PSP implementation theory”?  
The concept of the PSP implementation theory builds on related ideas such as the “logic 
model,”4 “treatment theory,”5 “program theory,”6 or “theory of change.”7-10 A longer overview of 
theory in quality improvement has been published by Grol and colleagues.11  
 
A logic model describes how an intervention is understood or intended to produce particular 
results.4 The logic model proposes a chain of events over time in cause-effect patterns in which 
the dependent variable (event) at an earlier stage becomes the independent variable (causal 
event) for the next stage.12 “Treatment theory” describes the process through which an 
intervention is expected to have its effects on a specified target population,” in this case, 
providers or organizations.5 This “small theory” is not a protocol that requires very specific 
prescribed actions. Instead, it is a set of principles that together are hypothesized to bring about 
change in the particular situation. These principles might be enacted in several different ways, 
but they all would achieve the same “functions” 13 and intermediate objectives on a chain of 
events that ultimately lead to improved patient outcomes.  
 
In the field of program evaluation, program theory is defined as the “conceptual basis” of the 
program: “Comprehensive evaluations address the theory by carefully defining the components 
of the program and their relationships and then examining the implementation of these 
components and how they mediate outcomes.”14 Experimental designs use “theory” in the sense 
that the evaluation is designed as a prospective test of a hypothesis. In contrast, in theory-
informed program evaluation, the program theory is either a prospective model of how the 
components lead to the intended results, or a retrospective explanation of how or why the 
program progressed as it did.6, 15, 16  
 
A “theory of change” is usually used to describe how those responsible for implementation 
understand an intervention to work.7-9 It may be explicit, or it may exist as a theory in the sense 
of being unspoken assumptions or beliefs. Dixon-Woods et al10 describe a theory of change as 
identifying “plans for change and how and why those plans are likely to work, and indicates the 
assumptions and principles that allow outcomes to be attributed to particular activities.” This is 
different from an explanation derived from empirical research on possible influences on 
outcomes. 
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These types of theories focus on the intervention and conceptualize it as a chain of events, often 
in a linear sequence, that lead through intermediate changes (including changes in provider and 
organizational behavior) to final results (clinical or cost outcomes). More sophisticated variants, 
often relevant to some combined or “bundled” safety interventions, view the implementation as a 
number of interacting components with a synergistic and system effect. 
 
A wider conceptualization of “PSP intervention theory” goes beyond the focus on the 
intervention and its causal chain to include an understanding of contextual influences and how 
they help and hinder implementation of the PSP. A contemporary example of this 
conceptualization is the realist evaluation idea of context-mechanism-outcome configurations—a 
theory of an intervention “triggers” action only in a particular context “primed” to be responsive 
to the intervention and where the intervention can “take hold.”17 As yet, the details of how to 
design and carry out studies to build these more complex “context sensitive” intervention 
theories are still being developed. An important difference from experimental designs is that 
influences other than the program are assessed for their influence on the program outcomes, i.e. 
the program is only one of a number of independent variables that are examined for their 
influence on the dependent variables. 
 
In summary, the "PSP implementation theory" builds on related concepts such as logic models, 
treatment theory, and program theory. In practice, use of any of these concepts would improve 
our current understanding of PSP implementations. 
 
Why do we need to know the “PSP implementation theory”? 
Systematic reviews of interventions to improve the quality and safety of care consistently 
indicate that most interventions, across different categories, are effective some of the time, but 
not all of the time, and that intervention effects range from none to large.18 However, very few 
such reviews are explicit about the underlying PSP action or implementation theories, let alone 
use them to explore causes of variation in effectiveness. Many studies of interventions to 
promote safety currently categorize features of interventions, targeted practices, and contexts on 
a superficial basis, e.g. computerized decision support systems (CDSS), prescribing, and urban 
hospitalsm respectively.2 Such classification systems are really descriptive typologies rather than 
theoretically meaningful groupings. They may be as unhelpful or misleading as classifying drugs 
into groups according to whether they are taken orally or intravenously or by the color and size 
of the pill.19, 20 It is not surprising that systematic reviews based on such categories or typologies 
raise more questions than they answer and struggle to extract generalizable lessons about how 
interventions achieve their effects.21 For example, a CDSS can work in a number of ways, such 
as by increasing knowledge of safe practice, reinforcing motivation, or prompting recall, and its 
effects may vary according to what types of clinical behavior are targeted, whether it is used with 
co-interventions, and so forth. The mechanisms by which more complex interventions work, 
such as those to reduce falls or rapid response teams, may be both more variable and more 
sensitive to contextual features.  
 
Therefore evaluations of PSP implementation need to address the processes by which 
interventions interact with contextual features and outcomes. For example, RCTs ideally should 
be accompanied by parallel process evaluations that assess the changes in processes, both 
intended and unintended, that may have contributed to changes in outcomes.22 
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Improving safety research with “PSP implementation theory” 
Theory has not commonly been used in the field of quality and safety research.23 Within a review 
of 235 implementation studies, only 53 used theory in any way, and only 14 were explicitly 
theory-based.24 Similarly, most reports of PSP evaluations do not provide theory or the logic 
model underpinning the intervention. Even for the five representative PSPs chosen for this 
project, which are among the most commonly studied PSPs, our review of publications of 
evaluations of the PSPs found only two articles that even partially reported a theory for why the 
PSP should work. 
 
Theory can guide or be applied to patient safety research in a range of ways, including the 
following. 
 
Explaining clinical and organizational behavior. Just as with clinical practice, it is important 
to diagnose the causes of adherence or non-adherence to recommended practice before 
intervening. For example, theories of human error suggest that there are several causes of 
discrepancies between intended plan and actual action, such as slips and lapses leading to the 
wrong execution of an action sequence.25 Recognition of such human limitations has led to better 
equipment design (e.g. alarms within anesthesia machines).26 
 
Selection or tailoring of patient safety interventions for a given problem and context. 
Previous research or practitioner reports can be used to create hypotheses or a provisional model 
of which actions may lead to which intermediate changes and which context factors may be 
important for implementation. Researchers can draw on this provisional implementation theory 
to decide which data to gather, or operationalize variables, to be able to describe implementation 
actions and intermediate changes, as well as which aspects of context were or were not helpful to 
the implementation actions. For example, McAteer et al.27 developed an intervention to increase 
levels of providers’ hand hygiene behavior using psychological theory for evaluation in a cluster 
randomised trial. This involved a review of effective behavior change techniques to inform the 
theoretical approach taken, development of intervention components with clinicians, and focus 
groups with the targeted provider groups. It may be that the customization of interventions is 
more necessary than we appreciate. 
 
Evaluating implementation and mechanisms of action. Theory can be used to help predict or 
evaluate the process of implementation, potentially distinguish between action theory failure and 
implementation failure, identify mechanisms of  action, and shed light on whether the PSP 
worked (or not) as hypothesized or by an alternative means, and identify unanticipated outcomes 
or unintended consequences. For example, Byng et al.28 conducted a qualitative interview study 
alongside an RCT of a multifaceted intervention to improve the care of people with long-term 
mental illness. They used a realist evaluation approach to delineate which aspects of the 
intervention had the greatest impact. 
 
It should be borne in mind that theory is not enough by itself to justify the implementation of a 
PSP. For example, a program theory may strongly suggest that an intervention works as 
predicted, but ‘triangulation’ via experimental or quasi-experimental data may fail to support 
this.29  
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Conclusions 
The “PSP implementation theory” is a representation of how actions lead to changes in provider 
and organizational behavior as a result of the PSP and, ultimately, affect patient outcomes. Yet, 
theoretical perspectives have, hitherto, seldom been incorporated into PSP evaluations. This lack 
of description and explanation of the assumptions or logic behind the PSP makes it more difficult 
for others to reproduce or adapt the PSP. Future evaluations should be theory-driven, in order to 
enhance generalizability and help build a cumulative understanding of the nature of change.  
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Chapter 8. Description of Ideal Evaluation Methods: 
Describing Patient Safety Practices 
 
One of the key issues in patient safety practice (PSP) research and literature is adequately 
defining and describing PSPs. The key goal in standardizing PSP descriptions is to provide 
sufficient detail on the PSP and its implementation to assess: (a) whether it improves safety, (b) 
the risks that random or systematic error influences the results, and (c) the applicability to other 
situations for others to replicate or adapt it. Other goals for standard descriptions include the 
ability to make biases transparent, evaluate inclusion criteria and determine heterogeneity in 
literature reviews, and improve the ability of journal editors and reviewers to assess the quality 
of the information. These goals require some basic information on the PSP itself and on key 
elements of what was done.  
 
Describing the intervention in sufficient detail so that it can be replicated is a requirement 
included in reporting guidelines such as SQUIRE for quality improvement studies, and it also 
was endorsed by our technical expert panel (TEP). The key challenge in PSP studies—in contrast 
to pharmaceutical or surgical interventions that are concrete or highly standardized and can be 
precisely defined, described, and delivered across settings—PSPs generally lack sharp 
boundaries between the practice, implementation process, and context. Indeed, as the science 
regarding effective implementation strategies and the understanding of context increase, 
implementation and context often merge together to become part of the intervention. PSP 
interventions are inherently dependent on context and vice versa—some PSPs include 
influencing context as part of the intervention. These interventions are often fluid, since some 
PSPs incorporate into "the intervention" unforeseen necessary adaptations or lessons learned 
during the implementation process. While this could be a major problem for clinical outcome 
studies (for example, if physicians were allowed to vary the dose of the study drug or add 
additional co-interventions at their discretion), the TEP felt that such fluidity was welcome in 
PSP studies as long as it was measured and described well. The intervention is often iterative, 
evolving in response to outcome feedback and changing as context changes through the 
implementation process. Finally, fully developed PSPs are often complex and include multiple 
components. While the knowledge regarding how to effectively implement a PSP and the effect 
of context on implementing a PSP is growing rapidly, it is still a relatively immature science. 
 
Existing descriptions of PSPs in the published literature vary widely, are often incomplete, and 
criteria to guide researchers on how to describe PSPs, the implementation strategies, or the 
contexts are lacking. Some organizations have produced criteria for describing a quality 
improvement intervention, which may have relevance to describing a PSP. For example, the 
SQUIRE guidelines are an important step in describing quality improvement studies generally 
aimed at directly changing provider behaviors.1 Table 2 contains an excerpt of the SQUIRE 
guidelines (the full set of guidelines is in Appendix M; see also http://squire-statement.org/). 
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Table 2. SQUIRE: Relevant elements (http://www.squire-statement.org/guidelines) 
Setting  
Planning the intervention  Describes the intervention and its component parts in sufficient detail that others could reproduce it. 
 Indicates main factors that contributed to choice of the 
specific intervention (for example, analysis of causes of 
dysfunction; matching relevant improvement experience of 
others with the local situation). 
 Outlines initial plans for how the intervention was to be 
implemented: e.g., what was to be done (initial steps; 
functions to be accomplished by those steps; how tests of 
change would be used to modify intervention), and by 
whom (intended roles, qualifications, and training of staff). 
Results  Outcomes.  Explains the actual course of the intervention (for example, 
sequence of steps, events or phases; type and number of 
participants at key points), preferably using a time-line 
diagram or flow chart. 
 Documents degree of success in implementing intervention 
components. 
 Describes how and why the initial plan evolved and the 
most important lessons learned from that evolution, 
particularly the effects of internal feedback from tests of 
change (reflexiveness). 
 
The NQF also lists requirements for describing quality improvement practices (See Table 3). 
These guidelines and requirements are generic for quality improvement interventions. 
 
Table 3. National Quality Forum practice description key elements 
The practice must be a  
clearly and precisely  
defined process or manner  
of providing health care 
services. 
 
 Target outcome or objective of practice - A specific description 
of the effect a practice is intended to have. 
 What does the practice entail? Specify elements that are 
considered to enhance the likelihood of achieving the target 
outcome for the practice and details related to implementation 
that would result in relatively uniform and comparable practices 
and outcomes across implementing entities. 
 For what encounters/patient populations is the practice 
indicated? 
 Who should perform the practice?  
 Theoretical or clinical rationale for the effect of the practice on 
target outcome. 
Readiness  What technology/tools are necessary to perform the practice? 
 What personnel qualifications are required to perform the 
practice? 
 What additional staff training is required for 
implementation? 
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No criteria exist for how to describe the key components of a PSP intervention. Thus, we 
developed general principles of a PSP description based on theory and existing frameworks. We 
also created two specific examples based on expert opinion from the project team. Key concepts 
for describing a PSP and additional elements that can be helpful are included in Box 1. In 
describing these concepts, we recognize that the borders between implementation and context are 
not sharp, and that the delineations may evolve as our understanding of important contextual 
factors grows. Currently, the line between what is context and what is PSP is often not clear. 
Likewise, the PSP and its implementation are usually too intertwined to tease them apart. The 
criteria we present here are limited by the lack of evidence to state what should be described 
about a PSP, so they should be considered as general concepts that appear to be important based 
on principles of behavior change, other guidelines, and the overall finding of this project.  
Box 1 - Key concepts in describing a patient safety practice 
Target: Patient safety problem practice is intended to address: 
- Key elements of the intervention. 
- Sufficient detail of the implementation process to allow relatively comparable adaptation to 
another entity. 
- Population or settings where practice applies; is the intervention intended to apply to a single 
level of the organization or multiple levels, and if so, how many? 
- Health care professionals and administrators that were involved. 
- Personnel qualifications and additional staff training. 
- Required technology or tools. 
Implementation detail should include
- Initial plans for intervention. 
:  
- Step-by-step explanation or diagram of intervention. 
- Description of elements key to association with improved outcomes. 
- Whether the PSP implementation requires education for executive leaders, team leaders or 
staff. 
- How the study or implementation team ensured that the executive leaders, team leaders, and 
staff executed the PSP implementation 
- How the study or implementation team evaluated whether the actions of executive leaders, 
team leaders, and staff made a difference. 
- Other barriers and facilitators of change and how these were addressed. 
- Steps for ensuring that the PSP was implemented as designed (or measuring how it was 
actually implemented and why changes were made). 
Other possible elements to include
- Factors that contributed to choice of the specific intervention (e.g., analysis of causes of 
dysfunction; other interventions that might have been considered). 
: 
- Resources used and which were required; feasibility. 
- Likelihood that observed gains may weaken over time. 
- Plans, if any, for monitoring and maintaining improvement (or state that such planning was 
not done). 
- Plans for moving from study to maintenance. 
- Ease of incorporating PSP into clinical practice or systems. 
 40 
- Generalizability of the elements of the intervention to other settings: unique features of the 
organization or external environment that may have influenced impact of the PSP. 
- Risk for unintended consequences. 
 
To supplement these generic criteria for describing the PSP, we provide here more specific 
criteria for describing two of our five target PSPs: catheter-related bloodstream infection 
prevention and CPOE. We solicited input from two members of the project, Peter Pronovost and 
David Bates, who are international experts in designing, implementing, and evaluating these two 
PSPs. As such, these criteria are based mostly on expert opinion. Nevertheless, in the absence of 
strong empirical evidence, the opinions of recognized experts can be a valuable source of 
guidance for implementers and evaluators. Criteria for describing interventions to prevent 
catheter-related bloodstream infections are presented in Box 2, and criteria for describing CPOE 
interventions are presented in Box 3. 
Box 2 - Case example: Key elements in describing PSP to prevent catheter-related 
bloodstream infections (CRBI) 
- Items on the checklist supported by strong evidence from the Centers for Disease Control and 
Prevention and professional societies. 
- Efforts to ensure patients receive checklist items. 
- Who is intended to do what task when the PSP is implemented? 
- Staff education and training. 
- Internal incentives. 
- Whether there was local tailoring or an iterative process in the intervention implementation. 
- Selection and involvement of leadership (unit and executive). 
- Improving patient safety culture and teamwork. 
- Providing evidence summaries and standardized measures. 
- Identifying local barriers. 
- Removing barriers to comply with checklist. 
 - Creating central line carts that store all needed supplies. 
 - Asking hospital leaders to purchase central line kits that have chlorhexadine. 
 - Improving culture and teamwork through the Comprehensive Unit-based Safety   
     Program. 
 
Box 3 – Case example: Key elements in describing studies of CPOE 
- To what extent clinical and operational leadership were involved in building support. 
- Staff education and training over time. 
- Extent of tailoring in implementation. 
- Pace of implementation. 
- Project management during implementation. 
- Response time of application. 
- Level of clinical decision support implemented. 
- What type of process was put in place to identify issues with the application and correct 
them? 
- Measurement of alert frequency and responses to alerts. 
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Our Proposed Framework for a PSP Classification System 
Through a process of synthesizing existing conceptual frameworks and an expert panel 
consensus process, we developed a conceptual framework for describing the dimensions of PSPs. 
The framework includes 11 dimensions, as shown in Table 4. The process of how this was 
developed is described in Appendix 2.  
 
Table 4. Classification dimensions for patient safety practices 
Dimension Definition and examples 
Regulatory versus voluntary Whether required by external entity, such as the Joint Commission 
Setting Hospital, nursing home, ambulatory 
Feasibility Ability to implement PSP in a variety of settings, even in small facilities12 
Individual activity vs. 
organizational change 
Whether the target of the PSP is individual providers’ behavior (e.g., 
handwashing) or the structure of the organization  
Temporal (one-time vs. 
repeated/long-term) 
 
Structural change (e.g., switch to antibiotic-impregnated catheters) or 
change that requires regular maintenance (e.g., hand hygiene education)  
Pervasive in setting vs. 
targeted to specific units or 
providers 
 
Whether the PSP addresses a safety issue that applies to all patients in 
a unit or setting (universal protocol would apply to all surgeries, but fall 
prevention would be targeted to at-risk patients) 
Common vs. rare event as 
target 
 
Whether the patient safety event that the PSP is intended to address is 
relatively common (e.g., medication errors) or rare (e.g., wrong-site 
surgery) 
PSP maturity, established vs. 
newer 
 
Whether the PSP has been well-studied, and implementation needs are 
well-known 
Degree of controversy or 
conflicting evidence (or both) 
 
Whether the PSP is widely accepted; whether examples of ineffective 
PSPs exist 
Degree of behavioral change 
required for implementation 
 
How much the PSP implementation involves human factors issues (e.g., 
an institutional policy switching to use of chlorhexidine would not depend 
on provider behavior) 
Sensitivity to context 
 
Whether the success of PSP implementation depends on issues such as 
leadership, patient safety culture, or teamwork  
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Chapter 9. Description of Ideal Evaluation Methods: 
Selecting Key Domains of Context 
 
As previously noted, we lack a universally agreed-upon definition of what constitutes "context."  
Context can be conceptualized as consisting of a discrete number of known constructs (e.g., 
organizational complexity, patient safety culture, etc.) all the way to everything that is currently 
unexplained or unknown about why a patient safety practice (PSP) implementation succeeds or 
fails. In our discussion with the technical expert panel (TEP), we constantly found ourselves 
asking (when considering a particular construct), "Is this context or is it part of the intervention?"  
Consequently, we determined that trying to reach agreement on what constitutes the boundaries 
of context would not be as fruitful as concentrating on a limited group of constructs that all 
agreed were important and could be considered contextual variables. Hence, in this report there 
is no overarching definition of what context "is," but rather thee is a determination and 
discussion of variables believed to be important in understanding PSP implementation and 
effectiveness that currently do not receive the attention they deserve. 
 
To begin this process, we used existing published papers regarding our five representative PSPs 
and our own knowledge to come up with a long list of potential influences on PSP effectiveness 
that might be considered context. We next surveyed the TEP in June 2009, and asked them to 
rate the importance of each contextual feature for each of the five PSPs. Based on the results of 
the survey, we developed a scheme for classifying and selecting PSP contexts for the next phase 
of the project. We attempted to take into account things like mutability (from the organization's 
perspective), whether PSPs were tactical or not (in terms of tactics that might be used to enhance 
implementation success), their measurement ability, and the evidence base supporting their 
importance. With input from the TEP, which included an Internet survey and a long 
teleconference discussion, we shortened the long list to a number of "high priority" contextual 
variables, which we then organized into four domains: 
 
1. External factors. These were all rated separately, were rated high in the Internet survey, and 
are related. Also, none are mutable from the organization's perspective but could be mutable 
by policymakers;  
 
2.  Structural organizational characteristics, such as size, complexity, and financial status or 
strength. These are not mutable and might have a bi-directional effect on PSP 
implementation, with increasing size and complexity facilitating some PSP implementations 
but making others more difficult; 
 
3. Teamwork, leadership, and patient safety culture. These were all rated separately and rated 
high in the Internet survey. Although it is unclear how independent they are, they all 
somewhat address the social or cultural aspects of a PSP implementation context;  
 
4. Management/implementation tools, including training resources, internal organizational 
incentives, audit and feedback, and collaboration with QI consultants. These are all factors 
that researchers can influence while implementing the intervention. 
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After reviewing the available literature regarding these contexts and our five representative PSPs 
(see Appendix A, Part 1, section on contexts), we then discussed these contextual variables in 
more detail with the TEP. As a result of this process, we separated an assessment of contexts into 
“important for describing context” and “important in assessing the effect of context on 
implementation success.” The former was judged to be important so that health care 
organizations could better assess the applicability of a PSP implementation to their own 
institution. We then conducted a second Internet-based survey of the entire TEP to determine 
which of the 32 contexts the TEP thought had a high priority for data collection. We asked the 
TEP to consider this question for each of the five PSPs when either assessing the effect of 
context on this PSP implementation or describing context in papers. The results of that survey 
are summarized in Table 5, which shows the contexts that respondents voted as “high priority” 
when assessing the effect of context or describing the context (full results of the survey are in 
Appendix D).  
 
Table 5. Results of Survey of High Priority Contexts 
Context 
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1. Structural Organizational Characteristics      
Size      
Location      
Financial status      
Academic status      
Organizational complexity      
Date of study      
Volume      
Existing quality/safety infrastructure      
Space/physical environment      
Past experience with IT      
Physician ownership      
2. External Factors      
Regulatory requirement      
Payments or penalties      
Local sentinel event      
Marketplace competition      
Competing demands      
3. Patient Safety Culture, Teamwork, Leadership      
Patient safety culture – org. level      
Patient safety culture – unit level      
Teamwork – org. level      
Teamwork – unit level      
Leadership – org. level      
Leadership – unit level      
4. Implementation and Management Tools      
Staff education and training      
Designated staff time to implement      
Use of audit and feedback      
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Internal or external person responsible for implementation      
Internal incentives      
Local tailoring or iterative process      
Helpdesk support      
Extent of project management      
Timeline of implementation      
Implementation process – 
one unit at a time or all at once 
     
Note: IT = information technology; org = organization; PSP = patient safety practice; CPOE = 
computerized provider order entry; DSS = decision support system 
Universal Protocol = for preventing wrong procedure, wrong site, wrong person surgery; 
Bloodstream Infection Checklist = catheter related 
 
Tools for Measuring Key Domains of Context 
One of the goals of the project is to suggest ways to measure contexts. Many of these contextual 
features have not posed a measurement problem in prior studies (i.e., size, location, academic 
status, regulatory requirement, use of audit and feedback, etc.). Other contexts do pose a 
measurement challenge, such as teamwork, leadership, patient safety culture, and organizational 
complexity. We concentrated on these four in our efforts to determine ways to measure context. 
To help guide a discussion of how these contexts might be measured, we did an extensive 
literature search in the health care peer-reviewed and “gray” literatures for measures. The 
measures we found for teamwork, leadership, and patient safety culture were sufficiently on 
target to include in subsequent activities. However, we did not find many measures of 
organizational complexity, even after expanding our search to the organization and business 
literature, such that we could not assess the relative strengths of measures of this context. 
Development of organizational complexity measures relevant for PSP evaluation remains an area 
for future development. All measures we found for the four contexts are listed in Appendix E.  
 
Given that there are multiple measures, and no one measure is superlative in all aspects, expert 
judgment is needed to help select the measures that might be more appropriate to use. As such, in 
late November 2009, we surveyed the TEP using another Internet-based survey to determine 
their opinions on some of the measures we found for teamwork, patient safety culture, and 
leadership (we did not survey the TEP on the measures of organizational complexity because 
there were too few). As in our prior survey about contexts, some TEP members abstained on the 
grounds that they were not expert in this area. We also heard from several TEP members that 
they did not think the field was sufficiently advanced to recommend specific measures. For 
example, one TEP member said: “I think this is beyond the scope (of what we can do),” and 
another TEP member said “this is futile, there are too many to choose from, and the choice of 
instrument would depend on the nature of the work being done.” Other panelists, while 
acknowledging that the evidence is too thin to support any one particular instrument, argued that 
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providing an expert opinion-based recommendation was still useful, since evaluators and 
researchers have choices that need to be made about which instruments to use, and the guidance 
of experts is better than no guidance at all. One expert put it this way: “Expert opinion is often 
the best we have at a moment in time, and making use of expert opinion is not, in any logical 
sense, tantamount to accepting or endorsing its validity. Nor does it preclude further and 
different work.” 
 
In the end, we received between 11 and 14 responses (depending on the context; out of 22 
possible participants) to our questions about which measures to use. This means that no measure 
could have received the 15 votes necessary for us to consider it the TEP recommendation. 
Furthermore, even when assessed as a proportion of actual respondents, no measure received 
endorsement above the 75 percent threshold that would constitute sufficient agreement for a 
recommendation from those who did respond.  
 
For these reasons, our conclusion is that the evidence base is too thin and agreement among 
experts insufficient to make strong recommendations about which measures are preferred for 
assessments of patient safety culture, teamwork, and leadership, suggesting the need for ongoing 
dialogue among researchers. However, for patient safety culture, the most support was given to 
the various AHRQ surveys relevant to this topic, plus the Safety Climate Scale1 and the related 
Safety Climate Survey.2 For teamwork, the most support was given to the ICU Nurse-Physician 
Questionnaire;3 no other measure received more than half the votes of respondents. Finally, for 
leadership, the measures receiving the most support were the ICU Nurse-Physician 
Questionnaire,3 the Leadership Practice Inventory, 4 and the Practice Environment Scale.5 No 
other measure received more than half the votes of respondents. The full results of the survey are 
presented in Appendix F.  
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Chapter 10. Description of Ideal Evaluation Methods: 
Measuring and Describing the Implementation Context 
Special contribution from Gery Ryan, Ph.D., RAND, Santa Monica, CA 
Clearly any attempt to replicate a patient safety practice (PSP) intervention will vary from 
context to context. If we wish to compare PSPs across contexts, then ideally we would like to be 
able to describe systematically each context to determine how it is similar to and different from 
each other context. We also need to determine to what degree (if any) these similarities and 
differences might have an effect on the effectiveness of the PSP intervention being studied. 
Measuring both the implementation process and how context influences the process are part of 
an ideal and rigorous evaluation. 
 
The context in which an intervention is being implemented can logically be divided into a 
description of two main categories: (a) the intervention and how it was operationalized and (b) 
the physical and organizational context in which the intervention was embedded. 
  
The Intervention Context 
All interventions can be described as someone doing something to someone else for a particular 
purpose. So, at a minimum, we need to clearly understand the following: 
 
3. Who are the interveners? 
a. How were they selected? 
b. What role do they play in the organization? 
c. What is their relationship with the intended intervenees (i.e., the targets of the 
interventions)? 
4. Who are the intended intervenees? 
a. How were they selected (if selected)? 
b. What role do they play in the organization? 
c. What is their role vis-à-vis patients? 
5. What specifically are the interveners doing to the intervenees?  
a. How consistent is the interveners’ behavior across intervenees (fidelity)? 
6. What (if any) new technology or changes to physical plant, organizational structures, or 
policies and procedures were introduced? 
a. To what degree do intended intervenees vary in their exposure to these changes? 
7. How is the intervention expected to influence the behavior of the intervenee(s)? 
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Consider the example of an education-based intervention to train front-line staff to wash their 
hands before and after contact with a patient. It would be ideal to know who was conducting the 
training, who they trained, what kind of training was provided, in what format, for how long, and 
how the training was expected to affect the specific behaviors of those trained. In some cases, the 
intervener may not seem obvious, for instance, administrators may change policies or may 
introduce new technologies or facilities. It is important to know if it was the quality control 
department that introduced new sinks outside of exam rooms on their own, or if it was the 
facilities department that made the decision because of new State regulations.  
 
Often interventions are made up of multiple components. Each component should be treated as a 
separate intervention and described in the manner above, although the action of the components 
may not be independent of one another. 
 
Knowing how each intervention component was operationalized is also important. At a 
minimum, we need to understand clearly the following:  
1. To what degree and how were expectations of the intervention made explicit to the intended 
interveners and intervenees? 
2. What (if any) kinds of positive and negative incentives (e.g., monetary, prestige, in-kind 
incentives, reprimands, or other disincentives) were used to motivate interveners or 
intervenees? 
3. How (if at all) was the performance of the interveners or intervenees monitored? 
4. What kinds of feedback or consequences (if any) did interveners or intervenees experience 
for meeting or not meeting what was expected of them?  
These latter four questions essentially describe the degree to which the expectations, incentives, 
monitoring procedures, and resulting consequences of an intervention (or an intervention 
component) have been made explicit to all the players involved. We find that evaluators often 
overlook these four topics in describing PSP interventions, but they do play a significant role in 
the intensity and success of a program. 
 
The Physical and Organizational Environmental Context 
To describe the physical and organizational context in which a PSP is embedded, implementers 
and evaluators first need to describe clearly the patient safety behavior that they are trying to 
improve and the range of people who are involved. Four types of players or organizational units 
are important: (1) the people directly responsible for ensuring that the patient safety behaviors 
are carried out; (2) the people who are responsible for initiating and carrying out the patient 
safety interventions; (3) the unit(s) within the organization where the patient safety behavior of 
interest is located; and (4) policymakers (e.g., at the State, Joint Commission, etc.). 
 
1. What is the patient safety behavior of interest? [Note: patient safety behavior can refer to 
changes in individual, organizational, or policy-level actions.] 
2. Who are all the players responsible for this behavior? 
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a. Who is responsible in the organization for establishing the standards and clear 
expectations regarding this particular patient safety behavior? For example, is this PSP 
something that is driven primarily from upper levels of the administration, or is it 
something that is championed primarily at the clinic level? 
b. What role does each player have in ensuring that the patient is not harmed? For example, 
in PSPs that involve information flow: Who is responsible for generating information that 
may or may not harm the patient? Who acts as a conduit for passing along such 
information? Who is responsible for ensuring that such information is accurate and 
remains accurate throughout the process? Note that some players may have important 
roles for each of these activities. The roles are somewhat different (and therefore have to 
be measured differently) for PSPs that are more behaviorally focused, such as hand-
washing. Here we want to know: Who is engaged in the behavior of interest, and who is 
responsible for monitoring (through direct or indirect means) that such appropriate 
behaviors are indeed being carried out?  
c. How are these players affected (if at all) by the intervention? This should include the 
players who are directly involved as part of the intervention; others that the players, in 
turn, are expected to influence; and the players who may be affected inadvertently. Take, 
for example, an intervention that provides guidance to nurses on how they can help 
monitor doctors’ hand-washing behavior. The intervention directly affects nurses, and 
intentionally, but indirectly, affects doctors. At the same time, the intervention may 
inadvertently affect nurse’s aides (in a positive manner) or may inadvertently affect the 
work load of administrators should tensions between nurses and doctors increase.  
d. What consequences are there for the players if they do not adequately perform their 
expected role vis-à-vis the patient safety behavior?  
e. Where are each of these players located in terms of the organizational structure? 
f. How does their performance on this patient safety issue affect others in their unit, 
division, organization? 
3. Who are the players responsible for initiating and carrying out the intervention? In any 
description of an intervention it is important to note explicitly who is doing what to whom. Some 
PSP interventions are commissioned by administrators and implemented by outsiders. Other 
interventions are championed, initiated, and carried out by insiders, and there are many 
combinations in between.  
a. Where are the initiators and implementers located in the organization? 
b. What role do they have in the organization? 
c. What motivates them to participate? 
d. To what degree do they motivate others? 
4. In what unit within the organizational structure is the intervention located? 
a. How important is this patient safety issue to the leadership of this unit? There are three 
fundamental ways to measure how important a PSP is to a unit. First, we can ask units to 
compare this PSP directly to other issues they may be addressing. The second and third 
approaches are a bit more indirect but much more empirically grounded. Here we can 
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describe the incentives and disincentives of high and low performance for the unit itself, 
as well as the incentives and disincentives the unit imposes on its members. For example, 
we could ask directly if the unit has an explicit list of priorities it wants to address and if 
so, where does this PSP fall on that list? More indirectly, we can first ask how (if at all) 
the unit is incentivized to report and improve their performance on this PSP? For 
instance, is the unit required to monitor their performance and report the results to upper-
level administrators? Is the unit’s performance compared with other units? Is the unit 
rewarded in any way for improvement? We can also ask how (if at all) the unit tries to 
monitor or incentivize its members to improve or achieve high performance. For instance, 
how regularly are unit members monitored? Does PSP performance affect a unit 
members’ career, salary, status, or prestige in any way?  
b. What (if any) consequences are there for the unit as a result of the success or failure of 
the intervention? Here, we want to know more about the stakes that surround the 
intervention itself. For example, is this an intervention being watched by trustees and 
hospital administrators? Is this an intervention that uses scarce resources that was chosen 
over other important priorities such that failure might breed ill will? Or is this one of 
multiple interventions being tried to improve PSP within the unit or hospital?  
c. What kind of resources (e.g., financial, labor, etc.), if any, has the unit contributed?  For 
example, for interventions focused on training and education, it would be useful to know 
how much time was spent by the trainers in preparing and presenting the materials, and 
how much staff time was required by the trainees? Further, was this staff time part of the 
regular work cycle, or was it considered extra work? If the latter, was this time 
compensated in any way? For interventions that require the acquisition of any new 
equipment or materials (e.g., sinks for washing hands, video cameras for monitoring 
performance, carts for wheeling around equipment and supplies), it would be useful to 
know the initial costs for purchasing and installing such equipment, as well as the cost of 
maintaining the equipment over time. 
 
After outlining the key components of an intervention’s context, the next step is to ask how each 
component should be reported or measured, and to what degree these reports or measures should 
be standardized.   
 
Although it is clear that having standardized, close-ended instruments would facilitate 
comparisons across cases and therefore make it easier to conduct meta-analyses, currently there 
are few (if any) validated instruments for measuring specific context components. Also, extreme 
caution is warranted to ensure that whatever standardized instruments are ultimately selected, 
they can be appropriately applied across the full range of PSP contexts. Taking instruments that 
have been developed for other purposes and simply applying them to intervention contexts is a 
risky venture. Picking inappropriate instruments (e.g., ones that are overly simplistic or 
complicated, lack face validity, are unreliable, or fail to capture the full range of issues) will 
make it more difficult (not easier) for researchers and decisionmakers alike to fully understand 
the context in which an intervention occurred.  
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The most practical way to standardize context is to use a staged approach that moves from an 
exploratory, open-ended approach of reporting context components, to a more systemized and 
close-ended approach to reporting the context.  
 
The first stage would standardize what particular context components were to be reported but not 
standardized specific instruments for how a particular content component was to be measured. In 
this stage, investigators would be presented with a list of key context components (such as the 
questions above) and asked to provide a description that is as detailed and honest as possible for 
each. Here, researchers would describe each context component in their own words, drawing on 
specific examples as appropriate. For example, consider the question “How important is this 
patient safety issue to the leadership of this unit (or units)?” We could imagine one case 
reporting that the intervention was one of the key PSP projects championed by the unit’s 
leadership—one they held up as a quality improvement example and one in which the director of 
the unit was personally involved and engaged. We could imagine another case reporting that 
intervention was recognized by unit leadership as one of many quality improvement practices 
being implemented, and that the unit leadership took notice and provided additional support once 
it became apparent that the intervention was generating noticeable results.  
 
By examining such descriptions across a range of different settings and different kinds of PSP 
interventions, we would begin to understand the range of ways in which “importance to 
leadership” could be potentially measured as a context effect. When we can combine these 
empirical results with what is found in the literature on leadership effects, we could begin to 
develop pilot, close-ended instruments for measuring different aspects of context. 
 
The second stage would then add such pilot instruments to the open-ended questions used in the 
first stage. Combining the open- and closed-end reporting styles would allow us to see to what 
degree the closed-end instruments capture the important nuances of the context, as well as to test 
their reliability across contexts. Only after the new closed-end instruments could be shown to be 
valid and reliable, should they be used exclusively as the standardized instrument for a particular 
context component. 
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Chapter 11. Description of Ideal Evaluation Methods: 
Assessing for Possible Harms 
 
All interventions can cause harms. Often these harms are unexpected adverse events. The 
methods of detecting unexpected adverse events are much less well developed than are the 
methods for detecting benefits, even for traditional assessments of efficacy or effectiveness of 
pharmaceuticals or devices. Long after having been studied for efficacy and receiving approval 
for use, unexpected associations have been discovered between COX-2 inhibitors and 
myocardial infarction, atypical antipsychotics and death in elderly patients, certain 
bisphosphonates and jaw osteonecrosis, and drug-eluting coronary stents and late restenosis. 
Therefore, our TEP judged an assessment of possible unintended adverse events to be an 
important criterion for an ideal evaluation of a PSP. They offered the following suggestions for 
how this might be accomplished: 
 
1. Before PSP implementation, spending designated time with the developers, the 
implementers, and organizational staff to brainstorm about what could go wrong is key (this 
exercise is sometimes known as a "pre-mortem" discussion). This can include a careful "walk 
through" of the logic model, assessing where problems may arise. More formal methods for 
prospective risk assessment could be used. For instance, failure modes and effects analysis 
has been used to anticipate changes (including what could go wrong) related to technology 
implementation.1-2  For potential adverse events foreseen by this process, evaluators can 
incorporate into the evaluation measurements of these potential harmful processes and 
outcomes and then include such information in their quantitative analysis. 
 
2. For adverse events that are truly unexpected, meaning that no amount of pre-implementation 
planning could account for them, direct interviews with organizational staff responsible for 
implementing the PSP would be one way to assess for their occurrence. Educators can then 
retrospectively ask questions such as, “How did this really work?” or “Did anything go 
wrong?” and then follow up appropriately. Another method is for the implementers to keep a 
log or diary of issues related to implementation and use of the PSP. The list of issues can 
then be analyzed to identify those issues that were anticipated and those that were not. 
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Chapter 12. Description of Ideal Evaluation Methods: 
Quantitative Approaches to Context Heterogeneity 
Special contribution from Naihua Duan, Ph.D., Columbia University, New York, NY 
 
Introduction 
Context often moderates intervention effectiveness; i.e., the effectiveness of an intervention 
might vary from site to site, depending on the contextual factors present at each site.1,2  This 
phenomenon is what we have termed context heterogeneity. This moderation effect is usually 
formulated statistically through the “intervention × context” interaction:  
 
(1a) Yi = b0 + b1 × Ti + b2 × Ci + b12 × Ti × Ci + εi,  
 
where i denotes the unit of analysis (usually the various sites in the study, but it can also be 
dyads of sites in matched comparisons), Yi denotes the outcome measure, Ti denotes the 
intervention status (Ti=1 for intervention, Ti=0 for control), Ci denotes the contextual factor, Ti 
× Ci denotes the “intervention × context” interaction, εi denotes random error, b0 denotes the 
intercept for the model, b1 denotes the main effect for the intervention, b2 denotes the main effect 
for the contextual factor, and b12 denotes the moderation effect for the contextual factor, i.e., the 
influence of the contextual factor on intervention effectiveness. 
 
As an example, consider a dichotomous contextual factor, say, C=1 denotes a teaching hospital 
and C=0 denotes a non-teaching hospital. According to model (1a), the intervention effect for a 
non-teaching hospital is given by b1, while the intervention effect for a teaching hospital is given 
by b1 + b12. If the moderation effect is absent (b12=0), the intervention effect does not vary 
between teaching and non-teaching hospitals. If the moderation effect is present (b12≠0), the 
intervention effect does vary between teaching and non-teaching hospitals, the difference being 
the moderation effect b12. 
 
Model (1a) presents the “intervention × context” interaction” for a single contextual factor. The 
model can be generalized in a straightforward manner to accommodate multiple contextual 
factors:  
 
(1b)  Yi = b0 + b1 × Ti + b2 × C2i + b3 x C3i + … + bk x Cki  
             + b12 × Ti × C2i   + b13 × Ti × C3i + … +  b1k × Ti × Cki + εi, 
 
where C2i, C3i,…, Cki denote multiple contextual factors, and b12, b13,…, b1k denote the 
respective moderation effects.  
 
The assessment of the moderation effect depends on the methodology used to assess the 
intervention effect. We discuss here eight scenarios. 
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Pre-Post Comparisons 
One option that could be used to assess the intervention effect is to compare the outcome 
measures pre- and post-intervention, without concurrent control sites. Under the assumption that 
the outcome measure is stable over time if no intervention were provided, any change observed 
would be attributed to the effect of the intervention. In particular, Model (1a) takes the following 
form: 
 
(2a) Y0i = b0 + b2 × Ci + ε0i, 
 
(2b) Y1i = b0 + b1 + b2 × Ci + b12 × Ci + ε1i, 
 
(2c) Y1i – Y0i = b1 + b12 × Ci + (ε1i – ε0i), 
 
where the subscript i denotes the i-th site in the study, Y0i denotes the pre-intervention outcome 
measure at the i-th site, Y1i denotes the post-intervention outcome measure at the i-th site; Ci 
denotes the contextual factor at the i-th site; ε0i and ε1i denote the respective error terms for the 
pre- and post-intervention outcome measures. Compared to Model (1a), the terms b1 × T and b12 
× T × C are absent in submodel (2a) because the intervention status T assumes the value T=0 
under the control condition. Similarly, in submodel (2b) compared to Model (1a), the 
intervention status T assumes the value T=1 under the intervention condition, therefore the terms 
b1 × T and b12 × T × C are given as b1 and b12 × Ci. Submodel (2c) compares submodels (2a) and 
(2b): the term Y1i – Y0i denotes the pre-post change, which measures the intervention effect at 
the i-th site.  
 
The moderation effect (b12 in Model (2c)) can be assessed by regressing the intervention effect at 
the i-th site, Y1i – Y0i, on the contextual factor Ci in model (2c). For continuous contextual 
factors, this regression analysis estimates the rate of change for the intervention effect at the i-th 
site, Y1i – Y0i, when the contextual factor Ci changes by one unit. For dichotomous contextual 
factors, this regression analysis simplified to a two-sample comparison, comparing the average 
of the intervention effect among sites with the contextual factor Ci=1 (such as teaching hospitals) 
versus the average of the intervention effect among sites with the contextual factor Ci=0 (such as 
non-teaching hospitals).   
 
The validity of pre-post comparisons depends on the validity of the assumption that the outcome 
measure is stable over time. If this assumption is questionable, e.g., if there is a possibility of a 
secular trend in the outcome measures, the validity of pre-post comparisons is questionable both 
for the assessment of intervention effect per se, and for the assessment of the effect of 
moderation for the contextual factors. 
 
Longitudinal Comparisons 
An important extension of pre-post comparisons is longitudinal comparisons of repeated 
measurements of the outcome measures over time, without concurrent control sites. Under the 
assumption that the outcome measure is stable over time if no intervention were provided, any 
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change over time that is observed would be attributed to the effect of the intervention. In 
particular, Model (1a) takes the following form: 
 
(3a) Y0i = b0 + b2 × Ci + ε0i, 
 
(3b) Yti = b0 + b1 × t + b2 × Ci + b12 × Ci × t + εti, 
 
(3c) Ri = b1 + b12 × Ci + δi, 
 
where the subscript i denotes the i-th site in the study, Y0i denotes the pre-intervention outcome 
measure at the i-th site, Yti denotes the outcome measure at time t for the i-th site; Ri denotes the 
rate of change for the outcome measure for the i-th site; Ci denotes the contextual factor at the i-
th site; ε0i and εti denote the respective error terms for the outcome measures; δi denotes the error 
term for the rate of change. We assume here that the trajectory of the outcome measure is linear 
over time, therefore the influence of time on the outcome measure in Model (3b) can be 
expressed as linear functions in time, t. Furthermore, the linearity assumption allows us to 
summarize the trajectory using the rate of change, R, in Model (3c): the rate of change for the i-
th site, Ri, can be estimated by regressing the outcome measures, Yti’s, on time, t, within the i-th 
site. It is of course possible to extend the model beyond linear trajectories and allow non-linear 
trajectories. 
 
In Model (3c), b1 measures the intervention effect for sites with null values for the contextual 
factor, such as non-teaching hospitals; for these sites, the outcome measures improve at the rate 
of b1 per unit time. For sites with C=1, say, teaching hospitals, the intervention effect is b1 + b12 
– the term b12 measures the moderation effect for the contextual factor C.   
 
The moderation effect (b12 in Model (3c)) can be assessed by regressing the rate of change, Ri, 
on the contextual factor Ci in model (3c).  
 
The validity of longitudinal comparisons depends on the validity of the assumption that the 
outcome measure is stable over time. If this assumption is questionable, e.g., if there is a 
possibility of a secular trend in the outcome measures, the validity of longitudinal comparisons is 
questionable both for the assessment of intervention effect per se, and for the assessment of the 
effect of moderation for the contextual factors. 
 
Matched Comparisons for Post-intervention Outcome Measures 
Another strategy that could be used to assess the intervention effect is to include concurrent 
control sites matched individually to the intervention sites and compare the post-intervention 
outcome measures across sites.1
                                                 
1 This strategy can be combined with pre-post comparisons, to be discussed in the following section. For now we 
assume that the pre-intervention outcome measures are not available. 
 We assume that the sites are matched on the contextual factor. 
Under the assumption that the matched sites differ only in the intervention status, the 
intervention effect can be assessed by the difference in the post-intervention outcome measures 
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for each dyad of matched sites. In particular, Model (1a) takes the following form under this 
approach: 
 
(4a) Y0i = b0 + b2 × Ci + ε0i, 
 
(4b) Y1i = b0 + b1 + b2 × Ci + b12 × Ci + ε1i, 
 
(4c) Y1i – Y0i = b1 + b12 × Ci + (ε1i – ε0i), 
 
where the subscript i denotes the i-th dyad of matched sites in the study, Y0i denotes the post-
intervention outcome measure at the control site in the i-th dyad, Y1i denotes the post-
intervention outcome measure at the intervention site in the i-th dyad; Ci denotes the contextual 
factor for both sites in the i-th dyads; ε0i and ε1i denote the respective error terms for the post-
intervention outcome measures. Compared to Model (1a), the terms b1 × T and b12 × T × C are 
absent in submodel (4a) because the intervention status T assumes the value T=0 for the control 
site. Similarly, in submodel (4b) compared to Model (1a), the intervention status T assumes the 
value T=1 for the intervention site, therefore the terms b1 × T and b12 × T × C are given as b1 and 
b12 × Ci. Submodel (4c) compares submodels (4a) and (4b): the term Y1i – Y0i denotes the 
difference between the intervention and control sites in the i-th dyad, which measures the 
intervention effect in the i-th dyad.  
 
The moderation effect (b12 in Model (4c)) can be assessed by regressing the intervention effect in 
the i-th dyad, Y1i – Y0i, on the contextual factor Ci in model (4c). For continuous contextual 
factors, this regression analysis estimates the rate of change for the intervention effect in the i-th 
dyad, Y1i – Y0i, when the contextual factor Ci changes by one unit. For dichotomous contextual 
factors, this regression analysis simplified to a two sample comparison, comparing the average of 
the intervention effect among dyads with the contextual factor Ci=1 (such as teaching hospitals) 
versus the average of the intervention effect among dyads with the contextual factor Ci=0 (such 
as non-teaching hospitals).   
 
The validity of matched comparisons depends on the validity of the assumption that the matched 
sites differ only in the intervention status. If this assumption is questionable, e.g., if there are 
important prognostic factors that differ between matched sites in the same dyad, the validity of 
matched comparisons is questionable, both for the assessment of intervention effect per se, and 
for the assessment of the effect of moderation for the contextual factors. If the unmatched 
prognostic factors are observed, it is possible to adjust for them using analysis of covariance 
(ANCOVA) models for post-intervention outcomes, or propensity scores analyses, to be 
discussed in Section F below. 
 
Matched Comparisons for Pre-Post-Intervention Changes in Outcome 
Measures 
Another strategy that can be used to assess the intervention effect is to combine strategies (A) 
and (B) and obtain both pre- and post-intervention outcomes measures for both intervention and 
control sites. The pre-post changes in outcome measures are compared across intervention and 
control sites to assess intervention effects. By combining pre-post and matched site comparisons, 
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this approach can be applied under weaker assumptions than the assumptions required for either 
strategy discussed in Sections A and B. In particular, this combined approach no longer requires 
the rather strong assumption in Section A that there is no secular trend. Instead, this approach 
only requires that any secular trend that might be present be the same between intervention and 
control sites in the same dyad. This assumption is also weaker than the rather strong assumption 
in Section B that the matched sites in the same dyad differ only in the intervention status. 
Instead, this approach allows the sites to differ in their pre-intervention status as long as these 
differences do not affect the pre-post change. In particular, Model (1a) takes the following form 
under this approach: 
 
(5a) D0i = b0 + b2 × Ci + ε0i, 
 
(5b) D1i = b0 + b1 + b2 × Ci + b12 × Ci + ε1i, 
 
(5c) D1i – D0i = b1 + b12 × Ci + (ε1i – ε0i), 
 
where the subscript i denotes the i-th dyad of matched sites in the study, Ci denotes the contextual 
factor for both sites in the i-th dyads. In submodel (5a), D0i denotes the pre-post change in the 
outcome measure at the control site in the i-th dyad, which measures the secular trend in the i-th 
dyad. Here we allow the secular trend to depend on the contextual factor. In submodel (5b), D1i 
denotes the pre-post change in the outcome measure at the intervention site in the i-th dyad. 
Submodel (5c) compares submodels (5a) and (5b): the term D1i – D0i denotes the difference in 
the pre-post change between the intervention and control sites in the i-th dyad, which measures 
the intervention effect in the i-th dyad.  
 
The moderation effect (b12 in Model (5c)) can be assessed by regressing the intervention effect in 
the i-th dyad, D1i – D0i, on the contextual factor Ci in model (5c). For continuous contextual 
factors, this regression analysis estimates the rate of change for the intervention effect in the i-th 
dyad, D1i – D0i, when the contextual factor Ci changes by one unit. For dichotomous contextual 
factors, this regression analysis simplified to a two-sample comparison, comparing the average 
of the intervention effect among dyads with the contextual factor Ci=1 (such as teaching 
hospitals) versus the average of the intervention effect among dyads with the contextual factor 
Ci=0 (such as non-teaching hospitals).   
 
The validity of matched comparisons depends on the validity of the assumption that any secular 
trend that might be present be the same between intervention and control sites in the same dyad. 
If this assumption is questionable, the validity of matched comparisons is questionable both for 
the assessment of intervention effect per se, and for the assessment of the effect of moderation 
for the contextual factors. If the unmatched prognostic factors associated with the secular trend 
are observed, it is possible to adjust for them using analysis of covariance (ANCOVA) models 
for pre-post changes, or propensity scores analyses, to be discussed below. 
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Matched Comparisons for Longitudinal Rates of Change in Outcome 
Measures 
A combined strategy similar to matched comparison of pre-post change, discussed in Section D 
above, is to combine strategies (A) and (C) and assess longitudinally the rate of change for 
outcomes measures for both intervention and control sites. The rate of change is compared across 
intervention and control sites to assess intervention effects. By combining longitudinal and 
matched sites comparisons, this approach can be applied under weaker assumptions than the 
assumptions required for either option discussed in Sections A and C. In particular, Model (1a) 
takes the following form under this approach: 
 
(6a) R0i = b0 + b2 × Ci + δ0i, 
 
(6b) R1i = b0 + b1 + b2 × Ci + b12 × Ci + δ1i, 
 
(6c) R1i – R0i = b1 + b12 × Ci + (δ1i – δ0i), 
 
where the subscript i denotes the i-th dyad of matched sites in the study, Ci denotes the contextual 
factor for both sites in the i-th dyads. In submodel (6a), R0i denotes the longitudinal rate of 
change in the outcome measure at the control site in the i-th dyad, which measures the secular 
trend in the i-th dyad. Here we allow the secular trend to depend on the contextual factor. In 
submodel (5b), R1i denotes the longitudinal change in the outcome measure at the intervention 
site in the i-th dyad. Submodel (6c) compares submodels (6a) and (6b): the term R1i – R0i denotes 
the difference in the longitudinal rate of change between the intervention and control sites in the 
i-th dyad, which measures the intervention effect in the i-th dyad.  
 
The moderation effect (b12 in Model (6c)) can be assessed by regressing the intervention effect in 
the i-th dyad, R1i – R0i, on the contextual factor Ci in model (6c).  
 
The validity of matched comparisons depends on the validity of the assumption that any secular 
trend that might be present be the same between intervention and control sites in the same dyad. 
If this assumption is questionable, the validity of matched comparisons is questionable both for 
the assessment of intervention effect per se, and for the assessment of the effect of moderation 
for the contextual factors. If the unmatched prognostic factors associated with secular trend are 
observed, it is possible to adjust for them using analysis of covariance (ANCOVA) models for 
longitudinal rate of change, or propensity scores analyses, discussed below. 
 
Adjusted Comparisons for Post-intervention Outcome Measures 
Matched comparisons discussed in Sections (B)-(E) above assume that the intervention and 
control sites can be matched to the degree required under each strategy. In practical applications, 
this usually is not a realistic assumption. Therefore, adjustment for covariates is usually 
important, both for studies in which matching is attempted and for studies in which matching is 
not attempted. The adjustments can made either using the analysis of covariance (ANCOVA) 
model, or the propensity scores analysis.3-6  
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With ANCOVA, Model (1a) takes the following form: 
 
(7a) Yi = b0 + b1 × Ti + b2 × Ci + b3 × Wi + b12 × Ti × Ci + εi, 
 
where the subscript i denotes the i-th site in the study, Yi denotes the post-intervention outcome 
measure for the i-th site, Ti denotes the intervention condition for the i-th site (T=1 if 
intervention, T=0 if control), Ci denotes the contextual factor for the i-th site, Wi denotes the 
covariates for the i-th site, and εi denotes the error term. The inclusion of the term b3 × Wi adjusts 
for the imbalance in the covariates, W, that might be present between the intervention vs. control 
sites. 
 
The coefficient b1 denotes the intervention effect for sites with null values of the contextual 
factor (C=0), such as non-teaching hospitals; the intervention effect for sites with the value off 
the contextual factor C=1, such as teaching hospitals, is given by b1 + b12. The coefficient b12 
denotes the moderation effect, e.g., how the intervention effect differs between teaching hospitals 
and non-teaching hospitals. 
 
The moderation effect (b12 in Model (7)) can be assessed (along with the other coefficients in the 
model) by regressing the post-intervention outcome measure, Yi, on the intervention status Ti, 
the contextual factor Ci, the covariates, Wi, and the interaction term, Ti × Ci, in model (7).  
 
With propensity score analysis, we first model the propensity for the i-th site to be an 
intervention site: 
 
(7b) πi = logit(P(Ti=1)) = g0 + g1 × Ci + g2 × Wi. 
 
The propensity model (7) is usually specified and fitted as a logistic regression of intervention 
status (T) on the contextual factor (C) and covariates (W). The fitted model is then applied to all 
sites in the study to derive the propensity score, π, for each site to be an intervention site. The 
propensity scores can then be used in several ways to adjust for the imbalance between the 
intervention and control sites in the sample. One option that is particularly suitable for the 
assessment of the moderation effect for the context factor, C, is the following ANCOVA model 
that uses the propensity score π instead of the covariates W in model (7a): 
 
(7c) Yi = b0 + b1 × Ti + b2 × Ci + b3 × πi + b12 × Ti × Ci + εi. 
 
Alternative ways that can be used to implement the propensity score analysis include matching, 
stratification, and weighting. 
 
The validity of adjusted comparisons depends on the success of the adjustment to remove all 
imbalances between intervention and control sites in the sample. With either ANCOVA or 
propensity scores analysis, it is necessary to assume that all relevant covariates are observed, i.e., 
there are no hidden confounders. 
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Adjusted Comparisons for Pre-post-intervention Changes in Outcome 
Measures 
Another strategy is to combine strategies (A) and (F), and apply ANCOVA or propensity score 
analysis to the pre-post changes in outcome measures.  
 
With ANCOVA, Model (1a) takes the following form: 
 
(8a) Di = b0 + b1 × Ti + b2 × Ci + b3 × Wi + b12 × Ti × Ci + εi, 
 
where Di denotes the pre-post change for the i-th site. The rest of the model is identical to Model 
(7a) discussed in Section F above. 
 
With propensity score analysis, the same propensity model (7b) is used to assess the propensity 
scores πi. The fitted propensity scores are then used in the following model: 
 
(8c) Di = b0 + b1 × Ti + b2 × Ci + b3 × πi + b12 × Ti × Ci + εi. 
 
Adjusted Comparisons for Longitudinal Rates of Change in Outcome 
Measures 
A combined strategy similar to adjusted comparison of pre-post change, discussed above, is to 
combine strategies (A) and (E) and compare longitudinally the rate of change for outcomes 
measures between intervention and control sites, adjusted for covariates that might be 
imbalanced, using either ANCOVA or propensity scores analysis.  
 
With ANCOVA, model (1a) takes the following form: 
 
(9a) Ri = b0 + b1 × Ti + b2 × Ci + b3 × Wi + b12 × Ti × Ci + εi, 
 
where Ri denotes the pre-post change for the i-th site. The rest of the model is identical to Model 
(7a) discussed above. 
 
With propensity score analysis, the same propensity model (7b) is used to assess the propensity 
scores πi. The fitted propensity scores are then used in the following model: 
 
(9c) Ri = b0 + b1 × Ti + b2 × Ci + b3 × πi + b12 × Ti × Ci + εi. 
 
The choice of analytic strategies for the assessment of intervention effect and the corresponding 
strategies for the assessment of the moderation effect for contextual factors depend on the design 
of the study. Strategies that are based on pre-post changes or longitudinal rates of changes can be 
applied only to studies that obtain pre-post measures or repeated measures of outcomes. 
Strategies that are based on matched comparisons can be applied only to studies designed with 
matched sites. In order to allow more flexibility in the analytic strategies, it would be 
advantageous to design the studies to include these features (either pre-post measures of 
outcome, or, more preferably, repeated measures; and matched sites).  
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The strategies discussed above are not exhaustive. Some of the strategies can be expanded, e.g., 
the linearity assumption in the longitudinal models can be relaxed to allow for non-linear 
trajectories over time. In addition, strategies such as instrumental variables analysis7 and causal 
sensitivity analysis6,8 can be used to address hidden bias, i.e., unobserved factors that are 
imbalanced between intervention and control sites. However, the eight strategies discussed above 
are probably the most practical methods and most commonly applied. 
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Chapter 13. Description of Ideal Evaluation Methods: 
Assessing the Strength of Evidence Across Studies of 
Patient Safety Practices 
A key step when conducting a systematic review is assessing the strength of the evidence across 
the studies of a particular topic. An extended discussion of this is included in Appendix H. 
 
One of the most widely used methods is that developed by the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) Working Group 
(www.gradeworkinggroup.org).1 GRADE has tools for grading the quality of evidence and the 
strength of practice guideline recommendations. These tools or related ones are already in 
widespread use by the American College of Physicians, the British Medical Journal’s Clinical 
Evidence, the Society of Critical Care Medicine, the Scottish Intercollegiate Guidelines Network, 
and more than 35 other organizations. An adaptation of GRADE has been published for 
diagnostic tests.2   
 
AHRQ’s Evidence-based Practice Center (EPC) program has developed its own method for 
assessing the strength of evidence, which started with GRADE but was adapted for the particular 
needs of the EPC program. The two methods share much in common, but they differ in the 
names they use for this construct as “quality of evidence” versus “strength of evidence” and in 
the labels and descriptors for the levels of evidence (Table 6). Also, GRADE suggests explicit 
weights for determining the level of evidence, while the EPC approach says that other methods, 
in addition to the GRADE weights, are acceptable as long as the method is transparent. 
 
The rationale for developing an adaptation of GRADE or the AHRQ EPC system for patient 
safety practices (PSPs) is that there are issues about PSP interventions (as detailed in this report) 
that differ sufficiently from the kinds of interventions that the existing GRADE or EPC system 
are most commonly used for (drugs, surgery, etc.), such that a modification may be more 
relevant to stakeholders than trying to apply the existing GRADE or EPC criteria.  
 
Table 6. Two methods for assessing the strength of evidence 
GRADE AHRQ EPC Program 
High = Further research is very unlikely to change 
our confidence on the estimate of effect. 
High = High confidence that the evidence reflects 
the true effect. Further research is very unlikely to 
change our confidence in the estimate of effect. 
Moderate = Further research is likely to have an 
important impact on our confidence in the estimate 
of effect and may change the estimate. 
Moderate = Moderate confidence that the 
evidence reflects the true effect. Further research 
may change our confidence in the estimate of effect 
and may change the estimate. 
Low  = Further research is very likely to have an 
important impact on our confidence in the estimate 
of effect and is likely to change the estimate. 
Low  = Low confidence that the evidence reflects 
the true effect. Further research is likely to change 
our confidence in the estimate of effect and is likely 
to change the estimate. 
Very Low = Any estimate of effect is very 
uncertain. 
Insufficient = Evidence either is unavailable or 
does not permit a conclusion. 
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In an adaptation for PSPs, we propose using descriptive categories similar to these. Using the 
GRADE and AHRQ EPC tools as a starting point, a tool to assess the strength of evidence across 
studies of PSPs might look like Table 7. This uses the EPC labels and the GRADE system of 
weights (+1, -1, etc.) and domains from both GRADE and the EPC schemes, plus adds key 
domains we identified during this project as relevant to evaluations of PSPs. 
 
Table 7: Criteria for assigning strength of evidence  
Does this evidence help me decide whether I can implement this PSP in my organization and get 
a similar result? 
Type of evidence 
Randomized trial = high 
Decrease score if: 
• No explanation of why the PSP might work, either in terms of theory, logic models, or prior 
success in other fields or in pilot studies (-1). 
• No reporting of contexts, including at least structural organizational characteristics, 
external factors, patient safety culture, leadership, teamwork, or implementation tools (-1). 
• PSP not described in sufficient detail to permit replication (-1). 
• No reporting of the implementation process, assessment of unplanned events, or changes 
to workflow (-1). 
• No assessment of the effect of contexts on implementation effectiveness (-1). 
Observational study = low 
Increase score if: 
• Consistent results obtained in multiple studies (+2). 
• Use of observational study designs of stronger internal validity (controlled before-and 
after, time series, statistical process control) (+1). 
• Very strong effect (+1). 
• Use of theory/logic models, assessment of contexts, reporting of implementation process, 
and fidelity of implementation (+1). 
Any other evidence = insufficient 
Across all study types, decrease score if: 
• Serious (-1) or very serious (-2) limitation to study quality. 
• Important inconsistency across studies (-1). 
• Imprecise or sparse data (-1). 
• High probability of reporting bias (-1). 
 
This approach takes into account many of the points made by this project. For example, RCT 
evaluations about a PSP that lack reporting of theory, context, implementation, etc. decrease the 
strength of evidence to moderate or even low. Likewise, a body of evidence about a PSP that 
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comes entirely from studies that are not RCTs can be considered high quality evidence if the 
studies use observational designs of stronger internal validity (such as statistical process control 
or controlled before-and-after); if they inform theory and measure and report contexts; or if they 
have very strong effects or consistent results are obtained in many studies. Our suggestion here is 
preliminary and would benefit from refinement from a varied group of PSP stakeholders. For 
example, one concept not yet incorporated into this scheme that deserves discussion is the 
concept of proportionality, meaning that interventions that are low cost and low risk (e.g., hand-
washing) may be accepted with a lower strength of evidence than interventions that have higher 
cost or risks (e.g., CPOE/DSS).  
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Chapter 14. Results: Needs for Future Development 
 
As described in our methods, we developed a list of 13 domains for future research. We then 
surveyed our technical expert panel (TEP) and queried which of these domains could be 
considered high priorities for future research. All 22 TEP members responded. Six domains 
received majority support as high priorities for future research (as bolded in Table 8).  
 
Table 8. Priorities for Future Research 
Domain 
Is a high 
priority for 
future 
research 
Not a high 
priority at 
this time 
Skipped 
question 
Developing/validating measures of leadership 10 11 1 
Developing/validating measures of patient 
safety culture 
13 9 0 
Developing/validating measures of teamwork 10 11 1 
Developing criteria/recommendations for 
what constitutes “reporting the intervention 
in sufficient detail that it can be replicated” 
14 8 0 
Understanding the important items to 
measure and report in implementation 
13 9 0 
Developing detailed methods for assessing 
potential unintended consequences 
7 14 1 
Developing evaluation methods for interventions 
that have very rare events as patient outcomes 
6 15 1 
Identifying critical aspects of context that 
influence PSPs not already considered in this 
project 
5 15 2 
Developing a theory-based taxonomy with 
which to describe and evaluate key elements 
of interventions, contexts, and targeted 
behaviors 
12 9 1 
Refining a framework for assessing the body 
of evidence about a PSP 
12 8 2 
Identifying barriers to conducting high quality 
research in patient safety 
4 17 1 
Conducting empirical research to show that 
the named factors from this project do make a 
difference 
14 7 1 
Evaluating the usefulness of another forum for 
communicating organizational experiences, other 
than peer-reviewed journals 
9 12 1 
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We now expand on these survey results with a summary of the TEP discussion of these topics.  
1.  Developing and validating measures of patient safety culture
 
. Discussion at the panel 
meetings indicated that several technical experts considered patient safety culture to be the 
overarching important construct. This view may explain why patient safety culture received 
majority support as a high priority for future research, whereas research on leadership and 
teamwork measures did not. Specific suggestions for future research included: 
a. Developing validated measures of cultural adaptability to change. 
b. Assessing the potential distinction between a culture of safety, a culture of excellence, 
and organizational culture. 
c. Establishing connections between aspects of patient safety culture and patient outcomes 
or processes of care. 
d. Assessing correlations between measures. 
 
Additional comments that we received can be summarized as “we think teamwork and leadership 
are important," "several measures are currently available," and "the most important thing at this 
point is for people to use them so we can start building some evidence about this construct.” 
 
2.  Developing criteria and recommendations for what constitutes "reporting the 
intervention in sufficient detail that it can be replicated.” More precise criteria for how PSP 
interventions should be described warrant additional research. In particular, the guidance 
described here, along with that provided by Standards for Quality Improvement Reporting 
Excellence (SQUIRE) and the National Quality Forum (NQF), needs to be evaluated. Doing so 
will help determine which PSP elements are necessary to describe in order to evaluate whether 
the PSP is truly effective. This also will help maximize the possibility of successful PSP 
replication with similar outcomes. Further research could also evaluate the effect of applying 
these draft criteria regarding PSP descriptions on the quality of PSP projects and published 
articles. Clearly, thoroughly describing PSPs also can help readers determine the relevance of an 
evaluation study to other PSPs or other contexts. For example, if a PSP requires an individual 
behavior change such as hand-washing, then knowing in detail what the intervention is may help 
readers of the study assess whether the given results are relevant only to hand-washing 
interventions or if they could be applied to other types of PSPs requiring individual behavior 
change. Knowing the details of the intervention also could help readers of the study determine 
how much the success of the PSP implementation depended on contextual issues (e.g., 
organization or teamwork).  
 
3.  Understanding the important items to measure and report on for implementation. 
Experts consider having comprehensive information about implementation key to being able to 
replicate a PSP. However, little empirical evidence exists about what makes a description of the 
PSP adequate for reporting. It is critical to assess what implementers need to know if they are to 
be able to implement or adapt an intervention in their own settings. Most experts considered 
"understanding the important items to measure and report on for implementation" to be related to 
or even the same as "reporting the intervention in sufficient detail that it can be replicated." This 
view suggests that the distinction between “the intervention” and “the implementation” may be 
an arbitrary line, and that ideal evaluations of PSP interventions need to consider the 
implementation as part of this intervention. 
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4.  Developing a theory-based taxonomy or framework with which to describe and evaluate 
key elements of interventions, contexts, and targeted behaviors
 
. Although the current project 
made a promising start on meeting this need, progress in this area will require additional 
development to produce a taxonomy that is both sufficiently broad based and flexible enough to 
be widely useful. Issues to be considered include whether a taxonomy is the preferable way to 
proceed, or whether a more useful strategy might be to create an explicit methodology that 
researchers could apply to specific problems and contexts. Yet another approach might be to 
devise an “assessment framework.” Some experts sounded cautionary notes on this topic. They 
reported that outpatient PSP research may be too new to apply a taxonomy at this stage. They 
also reported that a single “unified” taxonomy may not be sufficiently flexible for diverse PSPs, 
and multiple taxonomies may be needed in any case. The countervailing view to these cautionary 
notes was that the field would not be well-served by having a proliferation of taxonomies.  
Instead, they reported, what is needed is a coherent, sufficiently comprehensive taxonomy that 
can accommodate the challenges of the subject. 
5. Refining a framework for assessing the strength of a body of evidence
 
. We did 
developmental work on an adaptation of the GRADE and EPC systems for assessing the strength 
of evidence across studies of a PSP. This work warrants further development. 
6. Generating empirical evidence that the contextual factors identified in this project 
influence the success of the PSP
 
. We acknowledge that most of the recommendations in the 
report have a thin empirical evidence base, which simply reflects the relatively immature state of 
research in this still relatively young field. Building a stronger evidence base will help future 
efforts at refining the recommendations presented here.  
Additionally, the TEP acknowledged unintended consequences and rare events are important but 
not a high priority at this time. The issue of how to assess PSPs for context-sensitive beneficial 
outcomes in situations where the outcome is not rare was considered to be the more important 
priority. 
 
Continuing the TEP's Efforts  
We additionally queried the panelists about whether they would be willing to continue 
participating should AHRQ decide to continue this kind of methodological development work. 
All 22 panelists responded affirmatively, and many volunteered enthusiastic and laudatory 
comments about the process.  
 
Of the list of “high priority” items, those we judge most likely to be fruitful for additional work 
using this TEP are: 
• Developing a theory-based taxonomy with which to describe and evaluate key elements of 
interventions, contexts, and targeted behaviors. 
• Developing criteria/recommendations for what constitutes “ reporting the intervention in 
sufficient detail that it can be replicated” and the related topic of understanding the important 
items to measure and report in implementation. 
• Refining a framework for assessing the body of evidence about a PSP. 
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All three of these topics were discussed as part of this project, and this report contains the results 
of those discussions. But each of these, alone, could have been the focus of an entire 2-day TEP 
meeting, rather than the 1 or 2 hour allotment they received. Often we found we had to “move 
on” from a rich and insightful discussion in order to try and discuss all of the topics on this 
project’s agenda. Additional development of the preliminary ideas is needed, and this TEP is 
both an appropriate group to pursue this and already engaged. 
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Chapter 15. Discussion 
 
In this ambitious 1-year project we assembled a Technical Expert Panel (TEP) of patient safety 
experts, methods experts, and other stakeholders; met with the TEP three times; performed 
numerous literature reviews; conducted five Internet surveys; and achieved consensus on the 
following items: 
 
1. The following five patient safety practices (PSPs) represent a diversity of important domains, 
including setting, regulation, target of the PSP (in terms of individual clinician versus 
organizational change), a more common versus a more rare patient safety event, among 
others: 
a. Checklist to prevent catheter-related bloodstream infection.  
b. The Universal Protocol to prevent wrong procedure, wrong site, wrong person surgery. 
c. Computerized order entry/decision support system. 
d. Medication reconciliation. 
e. Interventions to prevent in-facility falls. 
Interpretation and significance: Subsequent efforts examining PSPs, by AHRQ and others, 
may wish to use this diverse and representative list of PSPs to help focus their work.  
 
2. Important evaluation questions for these PSPs are: 
a. What is the effectiveness of the PSP? 
b. What is the implementation experience of the PSP at individual institutions? 
c. What is the success of widespread adoption, spread, and sustainability of the PSP? 
Interpretation and significance: Evaluations of PSPs should explicitly consider these three 
questions. Journals should consider asking researchers to report on them separately. Also, 
implementers will want to assess their experience across all three questions. 
 
3. High-priority contexts for assessing context-sensitive effectiveness at individual institutions 
are: 
a. Structural organizational characteristics (such as size, location, financial status, and 
existing quality and safety infrastructure). 
b. External factors (such as regulatory requirements, the presence in the external 
environment of payments or penalties such as pay-for-performance or public reporting, 
national patient safety campaigns or collaboratives, or local sentinel patient safety 
events). 
c. Patient safety culture (not to be confused with the larger organizational culture), 
teamwork, and leadership at the level of the unit. 
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d. Availability of implementation and management tools (such as staff education and 
training, presence of dedicated time for training, use of internal audit-and-feedback, 
presence of internal or external individuals responsible for the implementation, or degree 
of local tailoring of any intervention). 
Interpretation and significance: Context is considered important in determining the 
outcomes of PSPs. The study investigators and the TEP judged these four domains as the 
most salient areas of context. This recommendation has broad implications for a variety 
of audiences. Researchers should be encouraged to measure and report on these contexts 
when describing a study of a PSP. Consumers of research will want to look for such 
reports, which will influence their interpretation of the study results and affect the 
applicability of the PSP to their setting. Accreditors and regulators should be reluctant to 
mandate adoption of a given PSP if it appears to be very dependent on context. In that 
case, they should also provide guidance on how that PSP might need to be modified 
depending on local contexts. 
 
4. There is insufficient evidence and expert opinion to recommend particular measures for 
patient safety culture, teamwork, or leadership. Given the plethora of existing measurement 
tools we identified and reviewed, our recommendation is to use whichever method seems 
most appropriate for the particular PSP being evaluated.  
a. For patient safety culture, the measurement methods with the most support were the 
AHRQ Patient Safety Culture surveys, the Safety Climate Scale, and the related Safety 
Climate Survey. 
b. For teamwork, the most support was given to the ICU Nurse-Physician Questionnaire; no 
other measure received more than half the votes of respondents. 
c. For leadership, the measures receiving the most support were the ICU Nurse-Physician 
Questionnaire, the Leadership Practice Inventory, and the Practice Environment Scale. 
Interpretation and significance: Because the four areas of context described under Point 2, 
above, are judged highest priority, it will be crucial to develop and use valid measures of 
them in PSP studies. Researchers' use of common validated instruments would better enable 
readers to evaluate whether published results are applicable to their own settings. The state of 
the science here is immature, and funders and researchers are encouraged to continue to 
develop standard measures of the key domains of context. 
 
5. The PSP field would advance by moving past considering studies of effectiveness as being 
“controlled trials” versus “observational studies.” Although controlled trials offer greater 
control of sources of systematic error, they often are not feasible, either in terms of time or 
resources. Also, controlled trials often are not possible for PSPs because they require large-
scale organizational change or PSPs targeted at very rare events. Hence, strong evidence 
about the effectiveness and comparative effectiveness of PSPs can be developed using 
designs other than randomized controlled trials. However, PSP evaluators are to be 
discouraged from drawing cause-and-effect conclusions from studies with a single pre- and 
post-intervention measure of outcome. More sophisticated designs (such as a time series or 
stepped-wedge design), are available and should be used when possible. 
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Interpretation and significance: Given the major push to improve patient safety and the 
focus on evidence-based practices (which are rapidly embedded in national standards 
such as those issued by the National Quality Forum, the Joint Commission, the Institute 
for Healthcare Improvement, and others), it will be crucial to develop standards for 
appropriate evaluations to answer key safety-oriented questions. The results above will 
help journal editors, funders, researchers, and implementers adopt robust study methods 
for PSPs, methods that most efficiently answer the key questions without undue bias. 
 
6. Regardless of the study design chosen, criteria for reporting on the following items in a PSP 
evaluation are necessary, both for understanding how the PSP worked in the study site and 
whether it might work in other sites: 
a. An explicit description of the theory for the chosen intervention components and/or an 
explicit logic model for “why this PSP should work.” 
b. A description of the PSP in sufficient detail that it can be replicated, including the 
expected change in staff roles. 
c. Measurement of contexts in the four domains described in Point 3, above. 
d. Details of the implementation process, what the actual effects were on staff roles, and 
how the implementation or the intervention changed over time. 
e. Assessment of the impact of the PSP on outcomes and possible unexpected effects. 
Including data on costs, when available, is desirable. 
f. For studies with multiple intervention sites, an assessment of the influence of context on 
intervention and implementation effectiveness (processes and clinical outcomes). 
Interpretation and significance: These criteria (items a-f) are deemed necessary for an 
understanding of PSP implementation and effectiveness and the degree to which these 
elements are sensitive to context. Future AHRQ-supported evaluations of PSP 
implementation should adhere to the criteria developed by this project. Only through 
repeated assessments and measurements will it be possible to determine the context-
sensitivity of PSPs and to build the evidence base for which contexts are most important and 
how they should be measured and reported. 
 
Limitations 
The strengths of our work to arrive at these criteria include the broad-based expertise and 
viewpoints within the project team and the TEP, the grounding of our work in theory and the 
practical assessment of literature, and the careful and painstaking process of consensus-building, 
through formal and informal group judgment processes. Limitations of our work are mainly the 
limitations of the state of the science: there is no agreed-upon definition of what is “context,” the 
boundaries between context and the intervention are often arbitrary, the intervention and the 
implementation of the intervention may often be considered to be a single construct, and there 
are insufficient data or expert opinion to specify in greater operational detail several of our 
important criteria, such as “description of the intervention in sufficient detail that it can be 
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replicated” or even what constitutes an adequate description of the use of theory. Furthermore, as 
already discussed, there is insufficient evidence and opinion to recommend specific measures for 
patient safety culture, teamwork, and leadership, even though these are three important contexts 
believed to influence intervention effectiveness. Lastly, our discussions were anchored by 
consideration of five specific PSPs. While they were chosen specifically to be diverse and 
representative, it is possible that contextual factors may be different for other PSPs. Our results 
could also benefit from a critical examination by an even wider-ranging group of patient safety 
stakeholders. 
 
